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ABSTRACT  
 
Monocytes are circulating blood leukocytes that arise from the bone marrow and are responsible 
for a wide array of homeostatic functions upon recruitment to different tissues. These phagocytes are able 
to mount an anti-microbial response, they are responsible for the production of a large array of cytokines 
and, importantly, they represent a pool of myeloid precursors that ultimately may originate tissue 
macrophages and dendritic cells.  Recently, several reports have shed light on the relation between 
metabolism and immune function, which has been vastly explored in groundbreaking research on the field 
of immunometabolism. The development of a specific immune response relies on the accurate utilization 
of certain nutrients, thus determining distinct metabolic phenotypes and consequently distinct effector 
functions. Although several reports state the importance of the metabolic environment for the correct 
function of macrophages, little is known about the impact of amino acids during monocyte differentiation. 
We are interested in studying the metabolic requirements of human CD14+ monocytes derived from 
peripheral blood mononuclear cells during differentiation in macrophage populations. The analysis of 
amino acid catabolism/anabolism by these populations, using high performance liquid chromatography, 
revealed distinct metabolic needs, depending on the differentiation profile. In order to assess the 
contribution of non-essential amino acids during differentiation, we cultivated the purified monocytes in 
conditioned media, where we selectively depleted L-aspartate. Moreover, the role of L-aspartate as a 
modulator of monocyte differentiation was assessed for several functional characteristics of macrophages 
such as phenotypical markers and other effector functions by flow cytometry. We observed that the 
differential availability of this amino acid during monocyte-to-macrophage differentiation impacts their final 
fate regarding function, thus showing a role for amino acid metabolism in the modulation of macrophage 
response.  
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RESUMO 
 
Os monócitos são leucócitos circulantes originários da medula óssea responsáveis por várias 
funções homeostáticas após recrutamento para diferentes tecidos. Estes fagócitos são capazes de 
desenvolver uma resposta anti-microbiana, produzir diversas citoquinas pró-inflamatórias e representam 
uma reserva de precursores mieloides, que podem eventualmente originar macrófagos tecidulares e 
células dendríticas.  
Recentemente, diversos trabalhos expuseram a relação entre o metabolismo e as funções imunes, 
um conceito que tem vindo a ser aprofundado na área do imunometabolismo. O desenvolvimento de uma 
resposta imune específica depende da correta utilização de certos nutrientes, o que por sua vez dita a 
existência de diferentes fenótipos metabólicos e, consequentemente, funções efetoras distintas. Apesar de 
diversos estudos demonstrarem a importância do microambiente metabólico para o desenvolvimento de 
uma função adequada dos macrófagos, pouco se sabe acerca do papel dos aminoácidos durante a 
diferenciação de monócitos. Este trabalho tem como objetivo estudar os requisitos metabólicos de 
monócitos humanos CD14+, derivados de células mononucleares do sangue periférico, durante a sua 
diferenciação em populações macrofágicas. A análise do catabolismo/anabolismo de aminoácidos, através 
de cromatografia liquída de alta performance, revelou diferentes necessidades metabólicas, consoante o 
perfil de diferenciação induzido nos macrófagos. De forma a entender a contribuição dos aminoácidos não 
essenciais durante este processo, os monócitos foram purificados e cultivados em meios condicionados 
em que o L-aspartato foi seletivamente depletado. O papel deste aminoácido como modulador da 
diferenciação de monócitos foi avaliado através do estudo de várias características funcionais dos 
macrófagos, como os marcadores fenotípicos e outras funções efetoras, que foram avaliados por 
citometria de fluxo. Neste estudo foi possível observar que a biodisponibilidade deste aminoácido durante a 
diferenciação dos monócitos em macrófagos tem um impacto no seu perfil final, nomeadamente em 
termos de função, o que demonstra um novo papel do metabolismo de aminoácidos na modulação da 
resposta dos macrófagos. 
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1. The impact of cellular metabolism on immune function 
 
The immune system is a crucial player on the homeostatic maintenance of any organism. It 
comprises adaptive and innate immune responses responsible for the protection of organisms 
against exogenous and endogenous pathogens or danger signals1. The adaptive system requires 
several days to mount a specific effective humoral and cellular response (characterized by T and B 
cells), which will recognize a particular antigen leading to the development of immunological 
memory2. While humoral responses are characterized by the production of specific antibodies by B 
cells, cellular responses are mediated by T cells after recognition of specific antigens delivered by 
antigen presenting cells. Adaptive immunity can provide long-time protection due to an acquired 
response that prepares the immune system for future challenges. On the other hand, the innate 
immune system, composed by proteins and cells involving phagocytes (dendritic cells (DCs), 
monocytes, macrophages (Mφ), neutrophils) or natural killer (NK) cells, is characterized by very 
rapid responses upon recognition of features common to pathogens or cellular damage3,4. The typical 
inducers of innate immunity are pathogen-associated molecular patterns (PAMPs) and damage-
associated molecular patterns (DAMPs), which instruct the initiation of effector responses through 
the activation of pattern recognition receptors (PRRs) such as “Toll-like” receptors (TLRs), 
“nucleotide-binding oligomerization domain receptors (NOD)-like” receptors (NLRs), C-type lectin 
Receptors (CLRs) or “retinoic acid inducible gene 1 (RIG-I)-like” receptors (RLRs). The recognition of 
intracellular or extracellular danger signals by these receptors allows the induction of distinct 
intracellular signaling to develop an efficient immune response. The combination of innate and 
adaptive responses allows the formation of a complex and robust immune response capable of 
eliminating the pathogen or recovering from the endogenous damage that originated a particular 
danger signal.  
Although innate immunity lacks the specificity of adaptive immunity, being this interpreted as 
antigen-specific, recent evidences have been changing the paradigm that only adaptive immunity can 
build immunological memory5. Indeed, both “innate immune memory” and “trained immunity” have 
been coined to characterize the innate immunological memory of past insults. The concept of trained 
immunity implies that monocytes and/or Mφ exhibit memory characteristics orchestrated by 
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epigenetic reprogramming, which mediate protective effects after a second signal or encounter with a 
pathogen. As an example, β-glucan was describe to train monocytes to produce increased levels of 
pro-inflammatory cytokines after contact with a secondary and distinct stimulus6. This enhanced 
response confers protection against some infections such as by Candida albicans7. Importantly, the 
modulation of these functional programs may be used as a cellular and molecular basis for vaccine 
development8. In opposition, monocytes can undergo a distinct functional program during 
inflammatory conditions known as tolerance. This term has been described as the unresponsiveness 
state of cells to repeated or prolonged stimulus such as lipopolysaccharide (LPS). The LPS tolerance 
leads to inhibition of TLR signaling and consequent to a decreased production of inflammatory 
cytokines9. Interestingly, exclusive epigenetic signatures have been considered responsible for the 
distinct phenotype between trained and tolerant monocytes10. The trained and tolerant cells display 
distinct metabolic requirements, which will fulfill different energetic needs. If in one hand, naïve and 
tolerant cells use preferentially fatty acid β-oxidation and oxidative phosphorylation (OXPHOS) as 
energy sources, trained monocytes rely mostly on enhanced glycolysis and fermentation11. Associated 
with distinct metabolic choices and epigenetic signatures, different effector functions are also 
associated with these subsets. Although the epigenetic and metabolic reprograming of these cells 
may render groundbreaking and innovative mechanisms for the development of protection against 
infections and mucosal tolerance, trained immunity programs may also originate maladaptive states, 
as in what happens during immune paralysis in sepsis5. During acute inflammation, as seen in septic 
conditions, leukocytes shift towards fermentation, with upregulation of glycolytic genes involved in the 
mammalian target of rapamycin-Hypoxia-inducible factor-1 alpha (mTOR-HIF-1α) pathway and 
increased secretion of lactate and nicotinamide adenine dinucleotide (NAD+) production. However, 
tolerant leukocytes (either induced in vitro through LPS exposure or extracted from septic patients), 
enter a state of immunometabolic paralysis11. This later stage of the disease is characterized by a 
shift to an anti-inflammatory stage, ultimately triggered to induce tissue repair but consequently 
leading to a premature inhibition of host defense pathways. These cells showed a defect in glycolytic 
and oxidative metabolism which is, on the contrary, characterized by an impairment of all major 
metabolic pathways, as seen by the decreased utilization of lipids and a diminished activation of 
mTOR11. 
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2. Monocyte and Macrophage development 
 
2.1. Monocytes: origin, development and fates 
Circulating monocytes are a heterogeneous population of cells that initiate the maturation 
process in the blood and, when recruited to the sites of inflammation, undergo further maturation 
and activation12. The heterogeneity of this population is associated with different origins and fates13. In 
the bone marrow, blood monocytes and DCs are originated from hematopoietic stem cells (HSCs) 
and this differentiation includes the transition to a common myeloid progenitor (CMP), which will 
subsequently generate granulocyte macrophage progenitor (GMP) and then the 
macrophage/dendritic cell progenitors (MDP)14. Afterwards, MDP gives rise to monocytes or to the 
common DC precursors (CDPs) (Figure 1)15. Thus, MDPs give rise to distinct types of blood 
monocytes characterized by the surface expression of Ly6C (glycosylphosphatidylinositol-anchored 
molecule) in mice or CD14 in humans. These cells are able to leave bone marrow to circulate in the 
blood vessels and then give rise to Mφ or to inflammatory DCs upon entrance in tissues. Upon 
recruitment, monocytes populate different tissues as Mφ displaying significant heterogeneity in 
terms of phenotype, homeostatic turnover and function15. If monocytes have not been recruited to 
tissues after two days in circulation, they die and are removed from the blood. Indeed, this short half-
life has suggested these myeloid precursors for optimal replenishment of tissue Mφ and DCs16. 
However, recent studies have shown that tissue-resident Mφ can self-maintain independently of 
HSCs and thus do not depend on monocytes originated from bone marrow myeloid precursors17,18,19. 
These resident Mφ originate from yolk-sac-derived erythrocyte-myeloid progenitors (EMPs) distinct 
from HSCs. The vast majority of adult tissue-resident Mφ in liver (Kupffer cells), brain (microglia), 
epidermis (Langerhans cells) and lung (alveolar Mφ) originate from the EMP in the yolk sac that 
migrate to the fetal liver during development20. Tissue-resident Mφ promote tissue homeostasis and 
present different characteristics and transcriptional profiles depending on the tissue21. For example, 
red-pulp Mφ in spleen regulate iron recycling, promoting red blood renewal; alveolar Mφ regulate 
pulmonary surfactant replenishment; osteoclasts promote bone regeneration22. Although these recent 
findings changed the initial paradigm that bone marrow progenitors were entirely responsible for 
replenishment of tissue Mφ through monocyte differentiation, it also reinforces the idea that Mφ are 
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a heterogeneous population, which display distinct functional programs depending on several factors, 
as the differentiation factors present in the microenvironment and epigenetic signatures originated 
though development.  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Development of blood monocytes from hematopoietic precursor cells. Hematopoietic stem cells 
produce monocytes and dendritic cells precursors (MDP) in the bone marrow via a myeloid committed precursor. MDPs 
give rise to monocytes, possibly through a pro-monocyte (dashed line), and pre-classical dendritic cells (Pre-cDC) and 
plasmacytoid dendritic cells (PDC) via a common dendritic cell precursor (CDP). In the mouse, two monocyte subsets 
Ly6C+ and Ly6C− leave the bone marrow to enter the circulation. The corresponding human monocyte subsets are shown 
in the light and dark purple boxes: inflammatory murine Ly6C+ and two human CD14+ subsets; and murine Ly6C− and 
human CD14dim monocyte subsets. Known subset specific functions are shown in bold in the light and dark grey boxes, 
while suspected functions are in italics. CD14+ monocytes respond to cells surface TLRs and are involved in inflammation 
and leukocyte recruitment, while CD14dim monocytes sense tissue damage and respond to viruses and nucleic acids via 
endosomal TLRs (TLR7 and TLR8). Monocytes may play an important role in autoimmune disease: patrolling mouse Ly6C− and human CD14dim via the production of tumor necrosis factor (TNF), interleukin (IL)-1β and chemokine (C-C 
motif) ligand 3 (CCL3) after recognition of nucleic acids, while murine Ly6C+ and human CD14+ monocytes can either 
activate or suppress T-cell responses. (Adapted from23) 
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Circulating monocytes are heterogeneous blood leukocytes responsible for a wide array of 
homeostatic functions24,25. They constitute 10% of all leukocytes present in a healthy human blood and 
approximately 4% of blood leukocytes in mice. During the process of development there is a clear 
definition of different subsets of these monocytes. In humans, peripheral blood monocytes are 
characterized based on their morphology and expression of different antigenic markers. The 
expression of CD14 (a surface marker involved in innate immune response to LPS) and CD16 (the Fc 
fragment of IgG receptor III - FcγRIII) surface markers on blood monocytes allow the discrimination 
and identification of three functional subsets of human monocytes26. The classic monocytes, 
CD14++CD16− represent approximately 90% of the human monocyte blood population under 
physiological conditions and are characterized by a higher phagocytic activity as suggested by the 
high levels of CD36 and CD163 scavenger receptors. This subset also present an optimal 
antimicrobial activity as demonstrated by the increased production of reactive oxygen species (ROS) 
and nitric oxide (NO) in response to bacteria. These monocytes also have an important role in 
leukocyte recruitment expressing high levels of C-C chemokine receptor 2 (CCR2) and low levels of 
CXC3 chemokine receptor 1 (CX3CR1). In opposition, the remaining 10% of human monocytes are 
characterized by the expression of CD16 marker, an important molecule for cytokine production. This 
population is sub-divided in the intermediate subset (CD14+CD16+) that expresses normal levels of 
CD14 marker and the non-classical subset (CD14lowCD16++), which presents lower levels of CD1426. 
Depending on the phenotypic expression levels of CD14, these two monocyte subsets play different 
functions in circulation. Both subsets expressed more TLRs 2, 4, 5, co-stimulatory molecules CD80, 
CD86 and Human Leukocyte Antigen – antigen D Related (HLA-DR) than the classical subset, 
suggesting their role in antigen presentation. Yet, while CD14lowCD16+ monocytes present 
‘inflammatory’ features on activation and have high antigen presenting capability, CD14+CD16+ 
intermediate monocytes appear to be transitional monocytes between classical and non-classical 
subsets displaying both phagocytic and inflammatory functions27. Moreover, the expression of high 
levels of CX3CR1 and low levels of CCR2, in opposite to classical monocytes, are characteristic of 
non-classic monocytes, being associated to the patrolling of the endothelium of blood vessels 
functions in steady state28. Some studies have also suggested that the expansion of the CD16+ pool of 
monocytes as an indicator of inflammatory diseases, being the main producers of tumor necrosis 
factor alpha (TNF-α) and interleukin (IL)-1β upon activation29. However, while in an acute 
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inflammation such as sepsis both classical and non-classical subsets increases, in a chronic 
inflammatory context as systemic lupus erythematous (SLE), only the non-classical subset is 
expanded27. 
The monocyte heterogeneity is conserved among mammals, as these different monocyte 
subsets have already been reported for other species30,31. For instance, in mice, circulating monocytes 
can be separated in two distinct subsets, according to their expression of Ly6C31. Ly6Chi CX3CR1low 
CCR2+ CD62L+ (L-selectin) monocytes present a gene expression profile that resembles the one 
observed in human classical monocytes. They comprise approximately 40% of the blood monocyte 
population, presenting higher migratory properties and being the main source of Mφ and DCs. On 
contrary, Ly6Clo CX3CR1hi CCR2- CD62L-, that resemble non-classical monocytes, represent 60% of 
monocytes and consist in a patrolling and long-lived cell population that maintain the homeostasis of 
endothelium32,31. As the human subset, Ly6Chi monocytes, when recruited to inflamed tissues, 
undergo activation and produce TNF-α, NO and ROS, and are able to stimulate effector T-cell 
proliferation33. However, it has been described that these cells may also have an important role in the 
suppression of T-cell activation34. Furthermore, Ly6Clo monocytes have also been associated with 
autoimmune diseases by the release of IL-1β and TNF-α in response to nucleic acids and viruses35. 
Similar to what happens with human CD16+ monocyte subsets, these cells also patrol the 
endothelium and protect the vasculature from tissue damage and infection and may be involved in 
the sensing of dying or infected cells through TLR736. 
Overall, the identification of these subsets and the understanding of their developmental 
program allow us to study their function in a physiological context and associate them with a specific 
fate mapping18. 
 
2.2. Monocyte Differentiation and Macrophage Polarization 
Blood monocytes and DCs, derived from CD34+ myeloid progenitor cells in the bone marrow, 
are always being replenished by the bone marrow precursors, even during adulthood37. These cells 
are regulated by colony-stimulating factors (CSFs) that mediate the survival, proliferation, 
differentiation and functional modulation of blood precursors and mature blood cells38. Macrophage 
9  
colony-stimulating factor (M-CSF, also known as CSF-1) and granulocyte–macrophage colony-
stimulating factor (GM-CSF) are the predominant promoters of monocyte differentiation39. The CSFs 
are distributed differently on myeloid cell populations40 and are capable of activate monocytic and 
macrophagic lineages41,42.  
M-CSF is ubiquitously produced by several tissues and controls Mφ frequency and number 
in many tissues43. M-CSF and IL-34 growth factors instruct cells to leave the bone marrow and to 
circulate in the bloodstream44. During this developmental stage, monocytes and their precursors 
express CSF-1 receptors (CSF-1R) that bind to M-CSF. The level of CSF-1R expression increases from 
hematopoietic precursors to monocytes and Mφ and the maturation process is controlled by the 
presence of M-CSF being its removal of circulation deleterious for monocyte proliferation, 
differentiation and survival45. GM-CSF plays also an important role in the Mφ and DCs network, since 
it presents low basal circulating levels that are often elevated during immune/inflammatory 
conditions46. GM-CSF receptors are also expressed on CD34+ progenitor cells and maturation of these 
progenitors into monocytic and granulocytic lineages leads to an increase in the expression of these 
receptors38,47. GM-CSF induces growth, differentiation, and survival of Mφ, granulocyte, erythrocyte 
and megakaryocyte cells from bone marrow progenitors and modulates the functions of mature 
effector cells such as neutrophils, Mφ and DCs38.  
Although monocyte subsets present different functions and have distinct fates, the monocyte 
and later Mφ plasticity allows them to respond to a variety of environment signals and undergo 
distinct differential profiles to maintain homeostasis48. Consequently, Mφ mature and become 
polarized to a particular specialized functional phenotype, usually clustered under the umbrella of the 
canonical pro-inflammatory M1 and anti-inflammatory M2 subsets49. These in vitro phenotypes are a 
clear reflection of Mφ function specialization. M1-Mφ (classically activated Mφ) result from the 
exposure to classical activating signals such as interferon-gamma (IFN-γ) and TLR ligands (e.g. LPS). 
These Mφ respond to further stimulation by secreting TNF-α, IL-12 and IL-6 and through the 
upregulation of surface expression of co-stimulatory molecules as CD86. This phenotype is 
associated with killing and degradation of intracellular pathogens due to the production of large 
amounts of NO and ROS. In the opposite extreme, M2-Mφ (alternatively activated Mφ) are induced 
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by certain anti-inflammatory cytokines as IL-4 and IL-13 and are associated to tissue remodeling, 
helminth infection clearance, tumor progression, adaptive immunity regulation and modulation of 
inflammation50,51,52. These Mφ also produce IL-10 and have an increased expression of scavenger and 
mannose receptors. In a similar manner, monocyte differentiation in response to M-CSF or GM-CSF 
growth factors leads to Mφ with distinct phenotypes53,54. Human monocytes are usually differentiated 
in monocyte-derived Mφ (MDM) using M-CSF (M-MDM) or GM-CSF (GM-MDM) as models for tissue 
Mφ39,55. GM-CSF in combination with IL-4 is also often used to induce the differentiation of human 
and mouse monocytes into DCs56. However it has been shown that the transcriptome analysis of 
these GM-MDM is more similar to Mφ than to DCs57. GM-MDM have been referred as M1-like Mφ 
and characterized by the production of pro-inflammatory cytokines. They exhibit potent microbicidal 
properties, thus promoting a strong IL-12-mediated T helper 1 (Th1) responses. On the other hand, 
M-MDM have been shown to have a repertoire of M2-like transcriptome with production of anti-
inflammatory cytokines with acquisition of certain functions that support T helper 2 (Th2)-associated 
effector functions and resolution of inflammation55. A similar profile has been associated to the 
polarization phenotypes of murine bone marrow-derived Mφ (BMDM)58,59. BMDM, after differentiation 
in the presence of M-CSF (M-BMDM), are an excellent model for studying M2-Mφ function and 
signaling60. Nevertheless, upon differentiation with GM-CSF (GM-BMDM) it originates a cluster of cells 
that display similarities with DCs but, like in humans, they have a transcriptome similar to M1-Mφ58. 
Hence, a comparative analysis of M-CSF- and GM-CSF-treated human and murine Mφ populations is 
essential to fully understand the function of these CSFs in MØ polarization and acquisition of 
biological functions, particularly in inflammatory diseases61. 
 
3. Immunometabolism 
3.1 . Overview of macrophage metabolism 
Growing evidences suggest that the polarization of Mφ is associated with a metabolic and 
bioenergetic reprogramming. Furthermore, the adopted metabolic pathways are a clear reflection of 
Mφ function and phenotype62. The accurate control of the involved metabolic pathways, which allow 
the fulfillment of the required biological activities, is essential to maintain homeostasis and a correct 
11  
functioning of Mφ. During the different stages that include development, proliferation, differentiation 
and the achievement of a particular effector function, immune cells demand an appropriate 
bioenergetic supply. For that to happen harmoniously, a crosstalk between the extracellular signals 
sensed by the immune system and the uptake and catabolism/anabolism of nutrients (glucose, 
amino acids, and fatty acids) is essential63. Upon a stimulus, the modulation of certain metabolic 
pathways is intrinsically connected to the regulation of cellular bioenergetics, thus supporting the 
development of an immune response. While before activation Mφ maintain a basal metabolic state, 
after a response to extracellular signals they undergo an extensive metabolic reprogramming 63. Yet, 
the anabolic and catabolic choices strictly depend on the type of stimulus received and are 
associated with the establishment of an effector response. During this process, the acquired 
substrates and their intracellular fate will be crucial for the synthesis of adenosine triphosphate 
(ATP), to feed the synthesis of macromolecules such as RNA, DNA, proteins or even lipids and 
glucose and to maintain the control of redox state of the cell (Figure 2)63. During the glycolytic 
process, the uptake of glucose via glucose transporters (GLUT) nourish distinct metabolic pathways: 
anabolic pathways, such as the pentose-phosphate pathway (PPP) that generates riboses (for RNA or 
DNA synthesis) and nicotinamide adenine dinucleotide phosphate (NADPH) (for fatty acid synthesis 
(FAS) and the respiratory burst of phagocytes) or the glycogen synthesis for increasing the energetic 
storages; and catabolic pathways, committed to the production of pyruvate, ATP and nicotinamide 
adenine dinucleotide (NADH). Under normoxic conditions, pyruvate may be used in the Tricarboxilic 
Acid (TCA) cycle for the formation of Acetyl-Coenzyme A (acetyl-CoA), which via the electron transport 
chain of OXPHOS leads to the production of ATP and co-factors important for other metabolic 
pathways.  Instead, in hypoxic conditions, the pyruvate is reduced to lactate, leading to the 
acidification of the extracellular environment. The Warburg effect, present mainly in cancer cells, is 
characterized by the production of ATP through high rates of glycolysis and subsequent production of 
lactate by fermentation. Even in the presence of oxygen, the pyruvate oxidation rate in mitochondria 
is low in comparison to the fermentative rate64. Similarly to what happens with carbohydrates, amino 
acids and fatty acids also can enter the TCA cycle and be catabolized to acetyl-CoA that replenishes 
the OXPHOS and allows ATP production. Besides its role in the synthesis of several macromolecules, 
acetyl-CoA is also involved in posttranslational modifications (namely acetylation) of histones and 
proteins, thus showing a great importance in other cellular processes apart from metabolism65. The 
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use of non-essential amino acids as glutamine provides a reinforcement of the TCA cycle and the 
PPP. Two anaplerotic reactions are used to fulfill the TCA cycle: the first converts pyruvate to 
oxaloacetate via pyruvate carboxylase, whereas the second converts glutamate to α-ketoglutarate via 
glutamate dehydrogenase.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  Major metabolic pathways of immune cells. Glucose enters the cells preferably through the GLUT1 
and is phosphorylated to G-6-P by hexokinases. During glycolysis, G-6-P is metabolized to pyruvate, reducing NAD+ to 
NADH and generating two ATP. In hypoxia, pyruvate is reduced to lactate, restoring NAD+ levels in the cell. In normoxia, 
pyruvate is metabolized to acetyl-CoA, which is oxidized in the TCA cycle to generate NADH. In the redox reactions of 
OXPHOS, electrons are sequentially transferred to generate a H+ gradient across the inner mitochondrial membrane, 
which drives the synthesis of ATP. In contrast to glycolysis, mitochondrial OXPHOS is a highly efficient form of generating 
ATP, yielding ∼30–36 ATP per molecule of glucose. Three additional pathways are shown; the PPP, glutaminolysis, and 
FAO. G-6-P is the entry point for PPP, which generates riboses for nucleotide synthesis. During this process, NADP+ is 
reduced to NADPH, forming the critical cofactor required for ROS production via the NADPH oxidase system in neutrophils and Mφ. During glutaminolysis, glutamine is metabolized to glutamate and subsequently to α-ketoglutarate, 
which then enters the TCA cycle. The fate of glutamine depends on the activation state of the immune cell; it can either 
be oxidized completely to generate ATP or used to replenish the metabolic intermediates of TCA cycles, which are 
diverted for macromolecule biosynthesis. The FAO yields acetyl-CoA, which enter the TCA cycle and OXPHOS pathways to 
generate ATP. (Additional abbreviations: GLUT1, Glucose transporter 1; G-6-P, glucose 6-phosphate; ATP, adenosine 
triphosphate; TCA, Tricarboxylic acid; ETC, electron transport chain; FAO, fatty acid oxidation; ROS, reactive oxygen 
species; NAD+, nicotinamide adenine dinucleotide; NADH, nicotinamide adenine dinucleotide hydrogen; OXPHOS, 
oxidative phosphorylation; PPP, pentose-phosphate pathway; FAO, fatty acid oxidation; NADP+, nicotinamide adenine 
dinucleotide phosphate; NADPH, nicotinamide adenine dinucleotide phosphate hydrogen.) (Adapted from 63). 
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Moreover, the glycolysis and TCA cycle pathways also provide intermediates for the 
biosynthesis of non-essential amino acids. For instance, the glycolysis intermediates 3-
phosphoglycerate and pyruvate are used as precursors for the synthesis of serine, cysteine, glycine, 
and alanine, whereas the TCA cycle intermediates oxaloacetate and α-ketoglutarate are used to 
synthesize aspartate, asparagine, proline, and arginine63. The biosynthetic reactions obtain energy by 
the continuum replenishment of the TCA cycle and glycolysis metabolic pathways66. Their existence in 
different immune metabolic pathways display a role in regulatory immune networks to control 
proliferation and immune cells function67,68. 
Importantly, another homeostatic control of cell is the redox state. The reduction of pyruvate 
to lactate allows the generation of NAD+ that is essential to sustain the redox state of the cell. The 
balance NAD+/NADH is maintained by a control of regulated pathways as TCA cycle and glycolysis. In 
mitochondria, the malate-aspartate shuttle and NADP+-dependent malate dehydrogenase also allows 
the balance of NADP+/NADPH, which is required for generation of ROS. The regulation of these 
distinct metabolic pathways on MØ permits the efficient polarization into distinct phenotypes that are 
associated to different metabolic requirements. 
 
3.2. Metabolic reprogramming and macrophage polarization 
The control of nutrient metabolism and the maintenance of cellular redox state are essential 
for a homeostatic performance of immune cells. The sensing of extracellular signals through cell-
surface receptors (as TLRs) leads to the activation of several metabolic regulators, such as the 
phosphatidylinositide 3-kinase/Protein kinase B (PI3K/Akt)/mTOR pathways, to initiate the required 
metabolic adaptations. The mTOR complex 1 (mTORC1) integrates the received signals and sense 
amino acids availability in order to control its import69,70. Nevertheless, the antagonism of 5'-adenosine 
monophosphate-activated protein kinase (AMPK) and mTOR activity appears to play a significant role 
in the regulation of the intermediary metabolism as bioenergetic sensors of cells. AMPK is modulated 
by hormonal and nutrient signals that in turn regulate food intake and energy availability, being a 
bioenergetic sensor essential in the regulation of cellular energy homeostasis. The role of this kinase 
in sensing energetic breaks lead to activation of catabolic pathways to obtain energy. On the other 
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side, AMPK inhibits mTOR, leading to inhibition of anabolic processes and to regulation of this 
intracellular nutrient sensor that controls protein synthesis, cell growth and metabolism71. 
Consequently, an equilibrium between these nutrient sensors allow nutrients to trigger metabolic 
switches that prime immune cells for their cell fate functions63. Genetic perturbations that prime or 
inhibit immune cell metabolism have a profound effect on their ability to undergo activation. For 
instance, deletion of c-Myc in mature T cells lead to inhibition of glycolysis and glutaminolysis 
pathways, which are crucial for the establishment of an effective proliferation process by these cells63. 
Besides, reprogramming of cellular metabolism is required for the proper polarization and functions 
of activated Mφ, as previously explained72. Recent evidences have begun to illustrate the 
mechanisms by which metabolism influences the functional phenotype acquired by Mφ under 
physiological and pathological conditions62. The metabolic variations impact the different polarization 
profiles adopted by Mφ that involve a continuum of functional phenotypes, canonically characterized 
by the in vitro M1 pro-inflammatory and M2 anti-inflammatory Mφ. The conception of metabolic 
requirements and effector functions of these Mφ are essential to understand the distinct phenotypes 
adopted by these cells (Figures 3 and 4). 
 
3.2.1. M1-macrophage polarization 
The induction of M1-Mφ upon activation by TLRs and pro-inflammatory cytokines, as IFN-γ, 
is associated with a pro-inflammatory and microbicidal phenotype73. In mice, one of the hallmarks of 
M1 polarization is the IFN-γ dependent expression of  high levels of inducible nitric oxide synthase 
(iNOS) that leads to the production of high quantities of NO74. M1-Mφ present a metabolic 
reprogramming associated with a high glycolytic rate involving an increase in glucose consumption 
with consequent high levels of lactate secretion (Figure 3)75. The fermentation of glucose is the 
preferred metabolic choice, since it allows these Mφ to rapidly meet their high energy requirements. 
Accordingly, the glucose transporter GLUT1 is the rate-limiting transporter on pro-inflammatory 
polarized Mφ76.  
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Figure 3. Metabolic profile of an M1 macrophage. Classically activated Mφ present a fermentative program that 
results in lactate production and increased levels of intermediates of the TCA cycle. The HIF-1α transcription factor 
becomes activated and drive production of pro-inflammatory cytokines. The key functional consequences are intracellular 
pathogen killing, mostly through the production of ROS and NO, and inflammation, which occurs via cytokine production. 
G6P, glucose-6-phosphate; F6P, fructose-6-phosphate; R5P, ribulose-5-phosphate; S7P, sedoheptulose phosphate; NO, nitric oxide; ROS, reactive-oxygen species; HIF-1α, hypoxia-inducible factor alpha. (Adapted from77). 
 
During phagocytosis, there is also an increase in glycolysis that may be explained by an 
induction of PI3K/Akt/mTOR pathway. The high glycolytic rate that M1-Mφ adopt allows their 
survival under hypoxic conditions given their lower necessity on oxygen-dependent mitochondrial ATP 
production functions78. Although glycolysis is less efficient in ATP production, the rapid production of 
ATP by cells allows the quick replenishment of energetic pools, which is important for cellular 
homeostasis64. Indeed, these high glycolytic rates practiced by Mφ permit a production of 
intermediaries that are used for the biosynthesis of other macromolecules. For instance, it has been 
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shown that classically activated Mφ present an increased activity of hexokinase and glucose-6-
phosphate dehydrogenase (G6PD), which suggests a metabolic shift between glycolysis and PPP in 
these Mφ79, essential for the synthesis of nucleic acids. In addition, the biosynthesis of other 
macromolecules such as lipids is also important for the membranes restructuration and, 
consequently, for the establishment of an effective immune response. In parallel, there is a decrease 
in turnover rates of TCA cycle, which are revealed by an accumulation of citrate and succinate 
intermediates80,81. For instance, in LPS-stimulated Mφ, the mitochondrial membrane potential is 
reduced to allow the cells to survive and maintain their function during an immune response82. It has 
also been shown that LPS upregulates the cationic amino acid transporter of L-arginine in these Mφ 
and the consequent NO production leads to a suppression of cellular oxidative metabolism by 
inhibition of electron transport chain enzymes83. The suppression of mitochondrial functions and this 
accumulation of intermediaries such as succinate in the cytosol leads to a stabilization of hypoxia-
inducible factor alpha (HIF-1α) that binds to IL-1β promoter and activates the sustained production 
of high levels of IL-1β, TNF-α and IL-6 by Mφ81. On the other hand, the stabilization of HIF-1α by 
inhibition of prolyl hydroxylase (PHD) protein, in the presence of succinate in cytosol, also leads to a 
higher glycolytic rate that is responsible for inducing ROS production81,76. The elevated GLUT1-driven 
glucose metabolism increases PPP that leads to the production of NADPH involved in ROS 
production. Lipidomics has also contributed to the understanding of the plasticity of lipid metabolism 
during Mφ activation. In that sense, citrate is another TCA cycle intermediate that accumulates upon 
LPS stimulation, resulting in its transport to the cytosol, where it serves as a precursor for fatty acid 
and phospholipid synthesis. In cytosol occurs the expansion of the Endoplasmic Reticulum and Golgi 
compartments to accommodate the increased secretory demand of M1 Mφ80. During Mφ response 
to TLRs, fatty acids may increase intracellular nuclear factor- κB (NF-κB) signaling. It has been 
shown that, in response to TLR4 stimulation, Mφ suffer lipid remodeling of glycerolipids, 
glycerophospholipids and prenols, which may impact its functions84. Therefore, the metabolic 
pathways chosen by immune cells contributes with rapid energy and reducing equivalents, which are 
crucial for their effector functions.  
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3.2.2. M2-macrophage polarization  
In contrast, the metabolic shift observed during M2 polarization is associated with low 
glycolytic rates while relying on fatty acid oxidation and oxidative metabolism for energy production 
(Figure 4)85. Cell-intrinsic lysosomal lipolysis has been considered essential in degradation of external 
triacylglycerol substrates via the scavenger receptor CD36, having a critical role in M2-activation86. 
However, endogenous lipid metabolism also contributes to Mφ phagocytosis by regulating 
membrane fluidity for the process. Nevertheless, M2-Mφ still present oxidative glucose metabolism 
through pyruvate oxidation in mitochondria to provide sustained energy for tissue remodeling and 
repair. This shift to oxidative metabolism allows the Mφ to meet the bioenergetics demands for long-
term activation. In mice, M2-Mφ are characterized by the hallmark expression of arginase (Arg) 
1dependent of signal transducer and activator of transcription (STAT) 6 and peroxisome proliferator-
activated receptor (PPAR)49,87, in particular due to a significant upregulation of PPARγ, a genetic 
sensor of fatty acids88. The latter plays an important role in Mφ lipid homeostasis since their deletion 
in Mφ impairs their ability to induce oxidative metabolism89. In response to IL-4 signal, PPARγ-
coactivator-1β (PGC-1β) has been shown to induce fatty acid oxidation and mitochondrial biogenesis 
in Mφ90. Indeed, expression of PGC-1β primes Mφ for alternative activation and strongly inhibits pro-
inflammatory immune response. Moreover, human Mφ present high levels of PPARα responsible for 
the regulation of cholesterol efflux91,87. PPARα also induces apoptosis and downregulates the 
expression of metalloproteinase in alternatively activated Mφ92. Besides, PPARδ controls an 
inflammatory switch through its association and disassociation with transcriptional repressors93. 
Moreover, IL-4-activated M2-Mφ are characterized by the high expression of mannose, 
scavenging and galactose receptors. These Mφ also present an efficient phagocytic activity and an 
increased production of polyamines by arginase pathway94. In contrast to what happens in M1-
stimulated Mφ, HIF-2α activation is detected in M2-Mφ, which leads to an induction of the 
expression of Arg1 and consequent suppression of NO production95. A significant induction of mTOR 
pathway inhibits M2 polarization, suggesting this molecule is also closely involved in the regulation of 
anti-inflammatory polarization96.  
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Figure 4. Metabolic profile of an M2 macrophage. Alternatively activated Mφ trigger a metabolic program 
including the electron transport chain as well as fatty acid β-oxidation, which is orchestrated by STAT6 and PGC-1β. Arg1 
also drives the production of polyamines and ornithine. The key functional consequences are tissue repair and anti-parasitic responses. PGC-1β, Peroxisome proliferator-activated receptor gamma coactivator 1-beta; Arg1, arginase 1. 
(Adapted from77). 
 
Overall, the plasticity related to metabolic modulation is exemplified by the blockage of 
oxidative metabolism, which prevents M2 polarization and reverts it to a M1 phenotype. Similarly, 
forcing oxidative metabolism in M1-Mφ potentiates the M2 phenotype75. Thus, the metabolic changes 
occurring during Mφ polarization appear to play an essential role in the determination of the 
activation and effector status of cells97. Although the key metabolic differences between differentially 
activated Mφ are currently accepted, the mechanisms and players responsible for orchestrating 
these different profiles at the molecular level remain largely unknown.  
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3.3. Amino Acid metabolism and Macrophage function 
Amino acid metabolism is largely associated with the establishment of an effective immune 
response. The molecular pathways involved in amino acid catabolism have shown to be important in 
the regulation of innate and adaptive immune responses during physiological and pathological 
conditions68. Nevertheless, the consequence of alterations in amino acid catabolism or anabolism 
remains unclear. Contrarily to essential amino acids, non-essential amino acids can be synthetized 
by the cells of the organism. Yet, immune cells are auxotrophs for several of these nonessential 
amino acids98. Glutamine and asparagine represent nonessential amino acids required by immune 
system to regulate immune responses. For instance, T cells present an obligatory requirement for 
high levels of glutamine for achieve an effective proliferation99.Besides, asparagine auxotrophy has 
also been described to be involved in cancer cell metabolism and the modulation of this amino acid 
may prove itself as a groundbreaking therapy against cancer cells. In fact, asparaginase, the enzyme 
responsible for catalyzing asparagine in aspartate, is already in clinical trials for several neoplastic 
diseases and it has been shown to inhibit tumor growth100. Due to the importance of these nutrients 
in several cell types, some studies intend to use catabolic enzymes for in vivo depletion of these 
indispensable amino acids101,102.  
The presence of amino acids may also be important for the development of effector 
functions. Regarding essential amino acids, leucine has been shown to activate mTORC1, thus 
leading to metabolic alterations in cell growth functions103. The mechanism of mTOR activation may 
be different in the presence of leucine, leading to an effective nutrient sensing mechanism essential 
for catabolism of cells103. In addition, another essential amino acid involved in immunometabolic 
regulation is tryptophan. It is a L-arginine-derived metabolite involved in regulation of 
immunosuppressive activity of myeloid-derived suppressor cells (MDSCs). Through activation of 
indoleamine 2, 3-dioxygenase 1 (IDO1), induced by TNF-α and IFN-γ stimulation, Mφ suppress T cell 
proliferation, thus decreasing inflammation104. Moreover, tryptophan is important for the de novo 
synthesis of NAD+. The rate-limiting enzyme IDO1 converts L-tryptophan in N-formylkynurenine, a 
biosynthetic precursor of NAD+, which in homeostatic levels assures an adequate environment for 
immune cells105. In spite of its known importance in the maintenance of redox cell homeostasis, NAD+ 
is also important in regulation of the production of inflammatory cytokines as TNF-α and IL-6 by 
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phagocytes106. It has also been shown that Mφ are able to block tumor growth through the 
consumption of arginine, thus increasing competition for this semi-essential amino acid107. However, 
a dual effect of L-arginine has been described in the context of Mφ polarization. Arginine is imported 
by activated Mφ through cation transporters as SLC7A2108 and then can be metabolized by two 
enzymes involved in its metabolism: iNOS and Arg1. iNOS metabolizes L-arginine leading to the 
production of NO and L-citruline and Arg1 uses L-arginine to the production of ornithine and urea109. 
Arg1 and iNOS compete with each other for arginine, however, the expression of these two enzymes 
is associated with different Mφ-polarized functions. Arg1 has an important role in the urea cycle and 
the deletion of this gene originates a lethal phenotype in M2-Mφ. In opposition, deletion of Arg2, the 
mitochondrial isoform of the enzyme, only leads to defects in biosynthesis of other amino acids such 
as glutamate, proline and citruline110. Overall, metabolic enzymes such as IDO1 and Arg1 that 
regulate amino acids availability are linked to the control of immunological mechanisms.  
Regarding non-essential amino acids, glutamine, the most abundant amino acid in 
circulation, is important for the establishment of an effective immune response by Mφ111. It is crucial 
for the development of an M2-like phenotype but it has no major effects in M1-Mφ profile112. 
Depletion of glutamine has been described to decrease the expression of genes associated to M2 
polarization, as chemokine (C-C motif) ligand (CCL) 22 gene. Additionally, glutamine shows an 
important role in inducing anaplerotic reactions that fulfill the TCA cycle113. Glutamine-driven 
glutamate is converted to α-ketoglutarate via glutamate dehydrogenase, which is an essential 
intermediate that completes TCA cycle contributing to the mitochondrial production of ATP. However, 
aspartate also contributes to anaplerosis by its conversion in oxaloacetate and consequent entry in 
the TCA cycle for activation of malate-aspartate shuttle, which transfers electrons to the inner 
mitochondrial membrane and produce ATP in the electron transport chain. Despite its importance in 
the production of ATP in mitochondria and biosynthesis of other amino acids, less is known about 
the effects of aspartate in immunometabolism. The induction of TCA cycle or, in contrast, the 
blockage of this amino acid catabolism may shift the metabolism in order to command cells to adopt 
different functions. Although the activation pathways involved in amino acids metabolism remain 
unclear in immune cells, new insights about amino acid metabolism may lead us to develop new 
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strategies that will allow a further understanding of their biological importance in immunoregulatory 
pathways.  
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Monocytes are cells of the innate immune system essential in the regulation of homeostatic 
functions upon recruitment to the tissues. The monocyte differentiation is an immune process with 
associated bioenergetic costs, being the utilization of certain nutrients indispensable for the accurate 
development of effector cells. However, how the acquisition of distinct metabolic phenotypes is 
handled during monocyte differentiation remains unclear. Moreover, less is known about the 
nutrients required during the differentiation process and in the acquisition of effective functional 
phenotypes. Accordingly, our main goals are to characterize the amino acid and carbohydrate 
metabolism requirements of human monocytes during the differentiation process and to understand 
how an altered amino acid metabolism may impact the acquisition of a metabolic and functional 
phenotype. Overall, our final objective is to deplete L-aspartate from the differentiation medium and 
assess how the differential availability of this amino acid during monocyte-to-macrophage 
differentiation impacts their metabolic and functional phenotype, thus showing a role for amino acid 
metabolism in the modulation of macrophage response. 
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1. Biological samples 
All experiments were conducted using buffy coats from healthy blood donors (n=23) supplied 
by Hospital de Braga. Ethical approval reference SECVF014/2015. 
 
2. Culture medium 
RPMI 1640 without amino acids (US Biological Life Sciences) was supplemented with 10% of 
heat-inactivated dialyzed FBS, Penicillin (100 U/mL), streptomycin (100 mg/mL) and 10 mM HEPES 
(all from Gibco, Life Technologies). Complete RPMI (RPMIc) was finalized by the addition of essential 
(MEM Amino Acids Solution, Gibco, Life Technologies) and non-essential amino acids suitable for cell 
culture: 2 mM L-Glutamine, 128 µM L-Alanine, 378 µM L-Asparagine, 136 µM L-Glutamic Acid, 133 
µM Glycine, 174 µM L-Proline, 285 µM L-Serine and 150 µM L-Aspartic Acid (all from Sigma 
Aldrich).  
 
3. Generation of monocyte-derived macrophages and dendritic cells 
Human peripheral blood mononuclear cells (PBMCs) were obtained from buffy coats using a 
density gradient centrifugation step (400g, 30 min at RT, Multifuge 3 S-R, Heraeus) with Histopaque-
1077 density solution (ratio 1:1) (Sigma Aldrich). Monocyte isolation was performed by 
immunomagnetic separation using anti-CD14-labelled microbeads (Miltenyi Biotec) according to the 
manufacturer’s instructions. In vitro differentiation into Mφ and DCs was performed during 7 days at 
37ºC, 5% CO2. Isolated CD14+ monocytes were washed in PBS, counted using a Neubauer chamber 
and cultured at a concentration of 5x105/mL in RPMIc with or without aspartate. Mφ were 
differentiated by cultivating monocytes in the presence of 20 ng/mL of GM-CSF or M-CSF, while DCs 
were obtained by cultivating monocytes with 20 ng/mL of IL-4 plus 20 ng/mL of GM-CSF 
(Peprotech). At day 4, the media was renewed using similar concentrations of each differentiating 
factor. At the 7th day of differentiation, Mφ were stimulated with 10 ng/mL lipopolysaccharide (LPS) 
(Escherichia coli O26:B6, Sigma Aldrich) for 24 hours. Unstimulated cells were used as control. The 
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supernatants were stored at -20ºC for posterior analysis and the cells were recovered for phenotypic 
analysis and effector function evaluation. 
 
4. Flow Cytometry Analysis 
The phenotypical and functional characterization of monocyte-derived Mφ and LPS-
stimulated Mφ was performed by flow cytometry (Supplementary figure 1). For the assessment of 
the phagocytic activity, fluorescent yellow-green latex beads (1.0 μm mean particle size) (Sigma-
Aldrich) were added to Mφ cultures at a ratio 1:10 (Mφ /beads) and incubated for 4 hours at 37ºC, 
5% CO2. Mφ were washed three times with FACS buffer (PBS with 2% FBS) to remove non-
phagocytized or adherent latex beads and acquired at the flow cytometer. Mφ with no incubation 
with the fluorescent beads were used as control. Mitochondrial mass and membrane potential were 
assessed by staining Mφ with 2.5 µM of 10 nonyl acridine orange (NAO) during 30 minutes at 37ºC 
and 400 nM of tetramethylrhodamine ethyl ester perchlorate (TMRE) during 15 minutes at 37ºC, 
respectively. Mφ intracellular nitric oxide was quantified by staining with 5 µM of 4-Amino-5-
Methylamino-2',7'-Difluorofluorescein Diacetate (Daf-FM diacetate) during 60 minutes at 37ºC. Total 
intracellular Mφ superoxide anion (O2-) and hydrogen peroxide (H2O2) production was evaluated with 
0.1 µM Dihydroethidium (DHE) and 10 µg/mL Dihydrorhodamine 123 probe (DHR 123), 
respectively, during 10 minutes at 37ºC (all from Molecular Probes, Life Technologies). For the 
phenotypical characterization, 2.5x105 Mφ were stained for surface antigens during 30 minutes at 
4ºC in the dark with the following monoclonal antibodies: PE-cy7 mouse anti-human CD163 1:25 
(clone GHI/61), APC mouse anti-human CD206 (MMR) 1:25 (clone 15-2), Brilliant Violet 711 mouse 
anti-human CD197 (CCR7) 1:12.5 (clone G043H7) and Pacific Blue mouse anti-human HLA-DR 1:25 
(clone 307633) (all from Biolegend). Subsequently, cells were washed FACS buffer to remove 
unbound antibodies and resuspended in FACS buffer prior to flow cytometric analysis. Single 
stainings for each fluorochrome was performed in unstimulated cells for fluorescence compensation 
and unstained cells were used as auto fluorescence control. Cell viability was assessed by 7-
aminoactinomycin D (7-AAD) staining labeling Mφ prior to analysis. In acquisition, cells were 
selected on the basis of forward scatter/side scatter values disregarding the dead cells. Data was 
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acquired on a LSRII flow cytometer with Diva Software and analyzed using FlowJo version 10 
software (TreeStar Inc.). 
 
5.  Cytokine production evaluation by Enzyme-Linked 
Immunosorbent Assay (ELISA) 
The concentrations of human IL-6, TNF-α and IL-10 were quantified on the supernatant of 
monocyte-derived Mφ in the presence of M-CSF or GM-CSF or upon a 24-hour LPS stimulation using 
colorimetric ELISA MAX kits (Biolegend), according to the manufacturer’s instructions. 
 
6. Amino Acid Quantification by High Performance Liquid 
Chromatography (HPLC) 
High Performance Liquid Chromatography (HPLC) was used to quantify the amino acid 
content in supernatants. For this, precolumn derivatization method using ortho-phthalaldehyde (OPA 
with methanol ≥99.9%, potassium borate 1M pH=9.5, and 2-mercaptoethanol ≥99.0%) 1:5 (Sigma 
Aldrich) was used to detect amino acids by a Gilson UV/vis_155 detector (338nm). Culture 
supernatants were filtered by Acrodisc 13mm syringe filters with 0.2µm supor membrane (Pall 
Corporations) previously to analysis and all mobile phases for elution were degasified for 30 minutes: 
inorganic mobile phase A, pH=7.8, was composed by Na2HPO4.2H2O 350mM:propionic acid 250mM 
(1:1) mixture (Merck) with acetonitrile HPLC grade in water (10:2:13) and organic mobile phase B 
was composed by acetonitrile, methanol and water (3:3:4) (HPLC grade, HiPerSolv Chromanorm, 
VWR Chemicals). Standard solutions of each amino acid were prepared in MilliQ water (Millipore): L-
aspartate, L-glutamate, L-asparagine, L-serine, L-glutamine, L-arginine, Glycine, L-threonine L-alanine, 
L-tyrosine, L-lysine, L-isoleucine, L-phenylalanine, L-methionine, L-tryptophan, L-cistine and L-leucine 
(all from Sigma Aldrich). A Gilson bomb system (Gilson) was used with a 40ºC Hi-Chrom C18 (model 
HI-5C18-250A) 5µm particles column (HiCrom). All data was analyzed in Gilson Uniprot Software, 
version 5.11. 
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7. Glucose and Lactate Quantification by High Performance Liquid 
Chromatography (HPLC) 
The quantification of glucose and lactate by HPLC was performed in supernatants previously 
filtered. A Gilson bomb system (Gilson, USA) was used with a 54ºC HyperREZ XP Carbohydrate H+ 
8µM (TermoFisher) column and a Refractive index detector (IOTA 2, Reagentes). The 0.0025 M of 
H2SO4 mobile phase was degasified for 30 minutes before being used. Standard solutions were 
prepared in MilliQ water (Millipore, Germany) and the calibration curves were previously made. All 
data was analyzed in Gilson Uniprot Software, version 5.11. 
 
8. Statistical Analysis 
Statistical analyses were performed in GraphPad Prism 6 using Oneway ANOVA test with a 
Bonferroni multiple-comparison posttest for multiple group comparisons and differences between 
groups were analyzed using Student’s t-Test. Statistically significant values are as follows: *p ≤ 0.05, 
**p ≤ 0.01, ***p ≤ 0.001 and ****p ≤ 0.0001. 
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1. Metabolic and phenotypical characterization of human macrophages 
and dendritic cells derived from CD14+ blood monocytes 
 
1.1. Amino acid metabolism evaluation in monocyte differentiation 
Amino acids play a key role in regulation of Mφ metabolism, cell survival, defense and 
effector mechanisms98. However, due to the lack of knowledge regarding the importance of amino 
acid metabolism during monocyte differentiation and in the acquisition of a phenotypical profile, we 
decided to evaluate amino acids metabolism during differentiation of human blood monocytes into 
Mφ or DCs. For that, we quantified the concentration of amino acids in the cell culture supernatants 
after 7 days of in vitro differentiation of human CD14+ monocytes with GM-CSF and M-CSF (both for 
Mφ differentiation) or IL-4 + GM-CSF (for DC differentiation). At the end of the differentiation process 
the levels of essential and non-essential amino acids were quantified by HPLC and compared to the 
initial concentration of each amino acid in the differentiation medium (Figure 5A-C and 
Supplementary figure 2). Positive values correspond to consumption while negative values indicate 
production of individual amino acids. Mφ differentiated from monocytes in the presence of GM-CSF 
or M-CSF presented similar amino acid catabolic and anabolic profiles. L-glutamine and L-aspartate 
were consumed in the presence of GM-CSF or M-CSF, while no differences were observed on L-
glutamate levels when compared to the initial culture medium. Our results showed a similar 
consumption of L-aspartate by Mφ on average of approximately 29 µM and 24 µM upon 
differentiation with GM-CSF or M-CSF, respectively, while no variation in concentration levels of L-
glutamate was observed. Although the consumption of L-glutamine was found to be significantly 
higher in the presence of GM-CSF when compared to M-CSF (350 µM and 130 µM, respectively; 
p≤0.01), the overall consumption profiles of these three amino acids appear to be independent of 
the factor used to differentiate Mφ from monocytes. During the DC differentiation process, we 
detected a significant increase on the consumption of L-glutamine (average of 480 µM; p≤0.0001) 
comparing to M-CSF differentiated Mφ. Consequently, and in opposition to monocyte derived-Mφ, a 
production of 110 µM on average of L-glutamate (p≤0.0001) was observed during dendritic cell 
differentiation. Also, we did not observe any modification on the L-aspartate levels during 
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differentiation, in striking contrast to Mφ differentiated in the presence of GM-CSF or M-CSF 
(statistical significance of p≤0.001 and p≤0.01, respectively). Moreover, no major alterations were 
detected regarding the metabolism of other non-essential and essential amino acids between 
monocyte differentiation in the presence of the different growth factors (Supplementary figure 2). 
Overall, our data suggested a distinct metabolic necessity for L-glutamate, L-glutamine and L-
aspartate between the differentiation of monocytes to Mφ, both with GM-CSF or M-CSF, and to DCs. 
Particularly, our data indicates L-aspartate as an amino acid whose consumption is significantly 
different between Mφ and DC differentiation. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Characterization of amino acids metabolism by human Mφ and DCs derived from CD14+ 
peripheral blood monocytes. The consumption or production of amino acids was quantified by HPLC in the 
supernatants of 7 days in vitro differentiated monocyte-derived Mφ (GM-CSF or M-CSF) or DCs (IL-4 + GM-CSF). The 
results are expressed as the concentration variation (µM) subtracting the concentration at the end of the differentiation 
process with the initial value of the differentiation medium. Positive values correspond to consumption levels, while 
negative values indicate production of L-glutamine (A), L-glutamate (B) or L-aspartate (C) (µM). Data was obtained from 
23 different donors. p values were determined and differences were considered significant for ** p ≤ 0.01, *** p ≤ 0.001 
and **** p ≤ 0.0001. 
A B C 
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The similarities observed between the amino acid metabolic profiles of Mφ allowed to 
positively and negatively correlate different amino acids profiles (Figure 6 and Supplementary figures 
3 and 4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Correlation of amino acids metabolic profiles of human Mφ derived from CD14+ peripheral 
blood monocytes. The consumption or production of amino acids was quantified by HPLC in the supernatants of 
monocyte-derived Mφ differentiated in vitro during 7 days with M-CSF (A, B, C) or GM-CSF (D, E, F). The concentration 
variation (µM) is represented as the subtraction of the initial concentration in the differentiation medium and the 
concentration of culture supernatant at the end of the differentiation process. Linear regression between the metabolic 
profiles of each amino acid in the culture supernatant is shown. Data was obtained from 23 different donors. r2 and p 
values were determined and differences were considered significant for p ≤ 0.05. 
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We observed a positive correlation between L-aspartate and L-glutamate 
consumption/production profiles in the presence of GM-CSF and M-CSF (r2=0.3300, p=0.0041 and 
r2=0.3296, p=0.0065, respectively) (Figure 6 A and D). In contrast, the results displayed negative 
correlations between L-glutamine and L-aspartate/L-glutamate during differentiation with M-CSF 
(r2=0.3982, p=0.0022 and r2=0.1885, p=0.0492, respectively) (Figure 6 B-C), which was not 
observed in the presence of GM-CSF (r2=0.0011, p=0.8811 and r2=0.0294, p=0.4344, respectively) 
(Figure 6 E-F). Moreover, neither positive nor negative significant correlations were found between 
these three amino acids after DC differentiation (Supplementary figure 3A-C). Although this suggests 
a role for L-aspartate, L-glutamate and L-glutamine during Mφ differentiation process, we also detect 
some other additional correlations between catabolic and anabolic profiles of other amino acids after 
differentiation in the presence of GM-CSF or M-CSF (Supplementary figure 4A-F). Correlations 
between L-aspartate and other amino acids such as L-serine, L-threonine and L-leucine were 
considered statistical significant in GM-CSF and M-CSF-differentiated Mφ. However, we decided to 
focus this work on L-aspartate, L-glutamate and L-aspartate catabolic and anabolic profiles. Based on 
these observations, we hypothesized that there is a metabolic link between the consumption and 
production levels of L-aspartate, L-glutamate and L-glutamine in the differentiation of human Mφ that 
could have an impact on their immune functions. 
 
1.2. Carbohydrate metabolism during monocyte differentiation 
The carbohydrate metabolism has been well studied during Mφ polarization, particularly 
upon stimulation with pro-inflammatory molecules. However, the role of carbohydrates and their 
metabolism during human monocyte differentiation into Mφ and DCs still remains unclear. Thus, we 
decided to perform a metabolic characterization of carbohydrate utilization during differentiation of 
human CD14+ monocytes in the presence of GM-CSF, M-CSF or IL-4 + GM-CSF. After differentiation 
with GM-CSF, Mφ present a significant increase in glucose consumption and lactate production 
when comparing to DCs (p=0.0060 and p=0.0290, respectively), which display lower levels of lactate 
production (approximately 2.5 mM on average) and irrelevant glucose consumption levels (Figure 7A-
B). These Mφ consume in average approximately 3.4 mM of glucose and produce 7.9 mM of lactate. 
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Although not significantly different, this glucose consumption and lactate production levels are higher 
when compared to the 1.3 mM of glucose consumption and 3.5 mM of lactate production levels 
obtained in Mφ differentiated in the presence of M-CSF. Despite these differences on individual 
glucose consumption and lactate secretion among the distinct stimuli, both types of Mφ and 
dendritic cells present similar lactate/glucose ratios (Figure 7C).   
 
 
   
 
 
 
 
 
 
 
 
Figure 7. Characterization of glucose consumption and lactate production by Mφ and DCs derived from 
CD14+ peripheral blood monocytes. Glucose consumption and lactate production levels (mM) were evaluated in 
culture supernatants after 7 days of in vitro differentiation with GM-CSF, M-CSF or IL-4 + GM-CSF growth factors. Positive 
values correspond to glucose consumption levels (A) and lactate production levels (B), while negative values indicate 
production of glucose (A). The ratio between lactate production and glucose consumption is also represented (C). Scatter 
charts reflect data obtained with cells derived from 23 different donors. p values were determined and differences were 
considered significant for * p ≤ 0.05 and ** p ≤ 0.01. 
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1.3. Phenotypical evaluation of macrophages and dendritic cells after monocyte 
differentiation 
Different subsets of Mφ can be evaluated through the quantification of distinct surface 
markers associated to Mφ differentiation and polarization. After monocyte differentiation, we 
analyzed the phenotypical profile of these cells through a flow cytometry panel of M1 and M2 
associated markers (CD197/HLA-DR and CD163/CD206, respectively) typically used to characterize 
populations of human Mφ and DCs. Indeed, CD206 and CD163 markers have been associated with 
a more anti-inflammatory profile of Mφ, while CD197 and HLA-DR have been linked to a more 
inflammatory profile of Mφ or to an activation state of DCs. When comparing GM-CSF and M-CSF 
differentiated Mφ, the proportion of cells positive to M2 markers CD206/CD163 was greater in the 
differentiation with M-CSF although not significant (Figure 8A). Yet, the percentage of Mφ positive to 
M2 markers in the presence of M-CSF was significantly higher when compared to differentiated DCs. 
Although a tendency was observed with the quantification of M1 markers, we did not observe any 
significant difference (Figure 8B). These findings show that M-CSF differentiated Mφ are to some 
degree more polarized towards an M2 profile than GM-CSF differentiated ones, although this division 
appears to be ambiguous. A further analysis on the mean fluorescent intensity of each marker 
consequently demonstrated that among the M2 markers, Mφ differentiated in the presence of GM-
CSF present a significant increase in CD206 expression, when compared to differentiation with M-
CSF (p=0.0386; Figure 8C). On the other hand, M-CSF-differentiated Mφ present a significant 
increase in CD163, comparing with GM-CSF differentiated Mφ and to DCs, which express only 
residual levels of this marker (p≤0.01 and p≤0.001, respectively; Figure 8D). Moreover, no 
significant differences were detected in CD197 and HLA-DR expression levels (Figure 8E-F). 
All together, these results contribute to a characterization of human monocyte differentiation 
in Mφ and DCs, which will allow a further understanding on how different growth factors may induce 
changes in human monocytes during the acquisition of different metabolic and phenotypical profiles.  
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Figure 8. Phenotypical characterization of surface markers of human Mφ and DCs derived from CD14+ 
peripheral blood monocytes. Flow cytometry phenotypical analysis of Mφ and DCs after 7 days of in vitro 
differentiation with GM-CSF, M-CSF or IL-4 + GM-CSF. Scatter charts represent percentage of CD206+ CD163+ (A) and 
CD197+ HLA-DR+ cells (B) and geometric mean fluorescence intensity values for phenotypical markers CD206 (C), CD163 
(D), CD197 (E) and HLA-DR (F), considering data obtained with cells derived from 23 different donors. p values were 
determined and differences were considered significant for * p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001. 
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2. Metabolic and phenotypical characterization of human macrophages 
derived from CD14+ blood monocytes in conditioned media 
 
After an initial characterization of CD14+ circulating blood monocyte-derived Mφ and DCs in 
a metabolic and phenotypical perspective, we recognized a correlation between aspartate catabolism 
and monocyte differentiation into Mφ. Interestingly, since this phenotype was specific for Mφ and 
not DCs, we were impelled to address the exact contribution of L-aspartate for the phenotypic and 
metabolic profile acquired by Mφ. For that, we differentiate in vitro monocytes into Mφ using GM-
CSF or M-CSF in a L-aspartate depleted media to address how this amino acid influence the 
phenotype, metabolism and effector function of Mφ after in vitro differentiation. Therefore, we 
started by characterizing amino acid and carbohydrate metabolism during in vitro monocyte 
differentiation in complete medium comparing to L-aspartate-depleted medium. We analyzed the 
phenotype acquired by the monocytes upon differentiation in these different media and evaluated the 
role of L-aspartate in metabolic requirements of Mφ differentiation.  
 
2.1. Amino acid metabolism evaluation during monocyte differentiation in conditioned 
media 
We started by evaluating the catabolic and anabolic profiles of amino acids in the 
conditioned media. Our goal was to understand if amino acid utilization was altered upon the 
conditioned deprival of L-aspartate during the differentiation process. Non-essential and essential 
amino acids catabolic and anabolic profiles were analyzed after 7 days of in vitro monocyte 
differentiation with GM-CSF or M-CSF in the presence of complete RPMI medium or in RPMI medium 
without L-aspartate. As a control, we quantified the L-aspartate levels in both media. As expected, no 
L-aspartate was found in the differentiated cells on conditioned media while on complete RPMI, Mφ 
consume approximately 20 and 34 µM of L-aspartate on average, with M-CSF and GM-CSF, 
respectively (Figure 9A and D). In the absence of L-aspartate, M-CSF-differentiated Mφ increase to 
approximately 40 and 200 µM of L-glutamate and L-glutamine consumption (p=0.0368 and 
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p=0.0134, respectively; Figure 9B-C) while GM-CSF-differentiated Mφ presented an increased 
consumption of L-glutamate (60 µM) but not of L-glutamine (p=0.0118 and p=0.1566, respectively; 
Figure 9E-F).  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Characterization of amino acids metabolism by human Mφ derived from CD14+ peripheral 
blood monocytes in conditioned media. Amino acid concentration variation (µM) in culture supernatants after 7 
days of in vitro differentiation with M-CSF (A-C) or GM-CSF (D-F) in conditioned media. Positive values correspond to 
consumption, while negative values indicate production of L-aspartate (A and D), L-glutamate (B and E) or L-glutamine (C and F). Data show mean values of Mφ differentiated in complete RPMI (RPMI) and mean values of Mφ differentiated in 
RPMI without L-aspartate (RPMI w/o ASP). Scatter charts represent data obtained with cells derived from 6 and 8 
different donors. p values were determined and differences were considered significant for * p ≤ 0.05. 
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Although we did not observe any alteration regarding the other analyzed amino acids 
consumption or production profiles in GM-CSF-differentiated Mφ, we detected increased 
consumption of L-serine, L-alanine and L-leucine after differentiation in the presence of M-CSF 
(Supplementary figure 5 and 6). This demonstrates that the amino acids L-glutamate and L-
glutamine are avidly consumed when Mφ are differentiated in medium L-aspartate depleted 
medium, which may represent a compensatory mechanism for Mφ differentiation. Nevertheless, we 
observed that while GM-CSF-differentiated Mφ showed a higher increase in the consumption of L-
glutamate, M-CSF-differentiated Mφ showed an increase in both the consumption of L-glutamine and 
L-glutamate. 
 
2.2. Evaluation of carbohydrate metabolism during monocyte differentiation in conditioned 
media 
We demonstrated that during monocyte differentiation in a medium deprived of L-aspartate 
Mφ compensate by upregulating the uptake and potentially the catabolism of other amino acids. We 
have previously observed that glucose is being consumed during monocyte-to-Mφ differentiation 
independently of the growth factor, which indicate that it might serve as a precursor for the 
production of ATP, NADPH and the synthesis of macromolecules such as nucleic acids. Thus, our 
next goal was to realize if macrophages also use carbohydrates as a compensatory mechanism in 
the absence of L-aspartate. To accomplish this, we decided to evaluate the levels of glucose 
consumption and lactate production in complete RPMI medium and compare it with glucose and 
lactate levels in supernatants of cells differentiated in the absence of L-aspartate. The results showed 
that the abolishment of L-aspartate during monocyte differentiation does not alter glucose 
consumption and lactate production profiles of Mφ during differentiation (Figure 10). The 
lactate/glucose ratios also showed no significant differences (p ≥ 0.05), which suggest that L-
aspartate abolishment do not alter the carbohydrate metabolism of Mφ differentiated in the presence 
of GM-CSF or M-CSF.  
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Figure 10. Characterization of glucose consumption and lactate production by human Mφ derived from 
CD14+ peripheral blood monocytes in conditioned media. Glucose consumption and lactate production levels 
(mM) were evaluated in culture supernatants after 7 days of in vitro differentiation with M-CSF (A-C) or GM-CSF (D-F) 
growth factors in conditioned media. Positive values correspond to consumption levels of glucose (mM) (A, D), production 
levels of lactate (mM) (B, E) or the ratio between lactate production and glucose consumption (C, F). Data show mean values of Mφ differentiated in complete RPMI (RPMI) and mean values of Mφ differentiated in RPMI without L-aspartate 
(RPMI w/o ASP). The charts reflect data obtained with cells derived from 6 and 8 different donors. p values were 
determined and no significant statistical differences were obtained. 
 
2.3. Phenotypical evaluation of macrophages after monocyte differentiation in conditioned 
media 
In order to assess the role of L-aspartate in the phenotypical characterization of monocytes 
differentiated with M-CSF or GM-CSF, we explored by flow cytometry the markers previously analyzed 
and compared their expression in Mφ after differentiation in complete RPMI medium or in RPMI 
medium without L-aspartate (Figure 11). Our results showed no statistical significant differences 
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between expression levels of CD206 (Figure 11A and E), CD163 (Figure 11B and F), CD197 (Figure 
11C and G) and HLA-DR (Figure 11D and H) markers upon monocyte differentiation in conditioned 
media, in the presence of M-CSF or GM-CSF.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Phenotypical characterization of human Mφ derived from CD14+ peripheral blood monocytes 
in conditioned media. Flow cytometry phenotypical analysis of Mφs after 7 days of in vitro differentiation with M-CSF 
(A-D) or GM-CSF (E-H) growth factors in conditioned media. The data represent mean values of geometric mean fluorescence intensity for phenotypical markers CD206 (A, E), CD163 (B, F), CD197 (C, G) and HLA-DR (D, H) of Mφ 
differentiated in complete RPMI (RPMI) or in RPMI without L-aspartate (RPMI w/o ASP). The charts consider data 
obtained with cells derived from 6 and 8 different donors. p values were determined and no significant statistical 
differences were obtained. 
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Although not statistical significant, we observe a tendency to increase the surface expression 
of CD206 marker when monocytes are differentiated in the absence of L-aspartate either in the 
presence of M-CSF (p = 0.0900) or GM-CSF (p = 0.1258). Overall, L-aspartate, a non-essential 
amino acid that can be synthesized by humans, influences the choice of amino acid catabolism 
without any impact on carbohydrate metabolism. Despite the absence of statistical significance, the 
observed tendency of increased surface levels of the M2 marker CD206 in the absence of L-
aspartate led us to perform further studies to characterize functionally the impact of L-aspartate on 
the differentiation of monocytes.  
 
3. Functional characterization of human monocyte-derived 
macrophages differentiated in conditioned media 
 
The metabolic and phenotypical characterization of CD14+ monocyte differentiated Mφ in 
medium lacking L-aspartate suggested an amino acid metabolic reprograming of monocytes. Thus, 
we decided to address how this metabolic adaptation may influence a functional phenotype of 
human monocyte-derived Mφ, once the functional characterization of these cells is essential for the 
understanding of their role upon recruitment to the tissues. 
 
3.1. Effector function evaluation of macrophages differentiated in conditioned media 
In order to evaluate the effector functions of Mφ differentiated in conditioned media, we 
started to measure the levels of cytokines production by Mφ after a 7 days in vitro differentiation with 
GM-CSF or M-CSF growth factors. Although not significant, M-CSF differentiated Mφ display a 
tendency to reduce the levels of IL-6 and TNF-α upon differentiation (p = 0.1407 and p = 0.0807, 
respectively; Figure 12A-B). No significant differences were found with the production and secretion 
of IL-10 (Figure 12C). The absence of L-aspartate during differentiation with GM-CSF do not alter the 
secretion levels of the pleiotropic IL-6 cytokine (p = 0.2987; Figure 12A). In opposition, we observed 
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a significant reduction on the release levels of TNF-α (p = 0.0334; Figure 12B) and a tendency to 
upregulate the IL-10 levels (p = 0.0723; Figure 12C). Overall, our data suggests that the absence of 
L-aspartate modifies the profile of secreted cytokines with a tendency for decreasing the 
inflammatory TNF-α cytokine secretion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Effector function evaluation measuring cytokine production levels after human monocyte 
differentiation into Mφ in conditioned media. Effector function was evaluated by the quantification of cytokine 
production in Mφ differentiated with M-CSF (A-C) or GM-CSF (D-F) factors in conditioned media. IL-6, TNF-α and IL-10 
concentrations (pg/mL) were measured by ELISA after differentiation in complete RPMI (RPMI) or in RPMI lacking L-
aspartate (RPMI w/o ASP). Scatter charts reflect data obtained with cells derived from at least 6 and 8 different donors. p 
values were determined and differences were considered statistical significant for * p ≤ 0.05 . 
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To further assess differences in the functional profile of Mφ after differentiation we pursuit 
our study by evaluating by flow cytometry specific functions of these cells, such as the production of 
ROS, NO and the percentage of phagocytosis (Figure 13). Due to the reduced number of samples 
tested so far and the similarities of the results obtained with M-CSF and GM-CSF differentiated Mφ, 
we choose to combine the data obtained with both stimuli in these following sections.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Effector function evaluation of human Mφ differentiated in conditioned media. Effector 
functions of Mφ were evaluated by flow cytometry analysis after in vitro differentiation with GM-CSF or M-CSF in RPMIc 
(RPMI) or RPMI lacking L-aspartate (RPMI w/o ASP). The production of ROS was evaluated measuring the production of 
superoxide anion (O2-) (A) and hydrogen peroxide (H2O2) (B). The production of nitric oxide (C) and the percentage of phagocytosis (D) were also assessed. The data was obtained derived from 6 different donors. p values were determined 
and no significant statistical differences were obtained. 
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Regarding the production of ROS, we measured by flow cytometry the levels of superoxide 
anion (O2-) and peroxide hydrogen levels (H2O2). Although not statistically significant, we detected a 
tendency for an increased production of these molecules in absence of L-aspartate (p =0.0913 and p 
=0.0518, respectively; Figure 13A-B). In opposition, the production levels of NO by these cells 
appear to decrease when differentiated in the absence of L-aspartate (p =0.0886; Figure 13C). 
Finally, no differences were found about the percentage of phagocytosed fluorescent beads between 
Mφ differentiated in the presence or absence of L-aspartate (p =0.4565; Figure 13D). Therefore, 
these results suggest that the absence of L-aspartate during differentiation may have an impact, 
although minor, on the production of oxygen and nitrogen reactive species, yet with opposite 
outcomes. To gain insight on a potential effect on mitochondria biogenesis and function, we also 
analyzed by flow cytometry the mitochondrial potential and mitochondrial mass after differentiation in 
conditioned media. Yet, no significant alterations on mitochondrial mass and membrane potential 
were found suggestive that the absence of L-aspartate do not interfere with mitochondrial biogenesis 
and structural integrity (p =0.1863 and p =0.1534, respectively; Figure 14A-B).  
 
 
 
 
 
 
 
 
 
 
Figure 14. Mitochondrial evaluation of human Mφ differentiated in conditioned media. Mitochondrial 
potential (A) and mass (B) were evaluated by flow cytometry analysis in monocyte-derived Mφ after in vitro differentiation 
with GM-CSF or M-CSF in RPMIc (RPMI) or RPMI lacking L-aspartate (RPMI w/o ASP). The data was obtained with cells 
derived from 4 and 6 different donors. p values were determined and no significant statistical differences were obtained. 
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Although we did not observed significant modifications on Mφ metabolic profile upon 
differentiation in the absence of L-aspartate, our data revealed a minor impact on several tested 
effector functions. Yet, we detected several tendencies that will be further explored in the future by 
increasing the number of individuals. Nevertheless, we further address how the absence of L-
aspartate impact Mφ functions upon an inflammatory stimulus.  
 
3.2. Assessment of effector functions of macrophages differentiated in conditioned media 
after stimulation with LPS 
We started to address the production of cytokines of Mφ differentiated in conditioned media 
upon stimulation with LPS during 24 hours. For that, we measured the production of IL-6, TNF-α and 
IL-10 cytokines by Mφ in order to unveil if there is any functional difference of these cells in response 
to a stimulus after differentiation in complete media or in media without L-aspartate. As referred 
previously, M-CSF differentiated Mφ display a more M2-like profile in opposition to GM-CSF 
differentiated ones. Indeed, the quantification of IL-6, TNF-α and IL-10 on the culture supernatants of 
24 hours LPS-stimulated cells perfectly show the higher levels of IL-6 and TNF-α achieved by the GM-
CSF differentiated Mφ while the opposite is observed with IL-10 levels (Figure 15). Similarly to what 
was obtained upon the analysis of the profile of cytokines produced at the end of the differentiation 
process, and probably due to the reduced number of individuals tested so far, we failed to obtain any 
statistical significance. Nevertheless, a similar tendency of decreased IL-6 and TNF-α secretion and 
increased levels of IL-10 was observed upon LPS stimulation on M-CSF differentiated Mφ in the 
absence of L-aspartate (p = 0.2143, p = 0.2672 and p = 0.1285, respectively; Figure 15A-C). Yet, 
this phenotype was not observed with GM-CSF differentiated Mφ (Figure 15D-F).  
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Figure 15. Effector function evaluation measuring cytokine production levels after human monocyte 
differentiation into Mφ in conditioned media upon stimulation with LPS. Effector function was evaluated by 
the quantification of cytokine production in 24 hours LPS-stimulated Mφ after 7 days of in vitro differentiation with M-CSF 
(A-C) or GM-CSF (D-F) in conditioned media. IL-6, TNF-α and IL-10 concentrations (pg/mL) were measured by ELISA after 
differentiation of Mφ in RPMIc (RPMI) or in RPMI lacking L-aspartate (RPMI w/o ASP). Scatter charts reflect data 
obtained with cells derived from at least 6 and 8 different donors. p values were determined and no significant statistical 
differences were obtained. 
 
We also assessed specific effector functions of Mφ after stimulation with LPS, such as ROS 
and NO production, and phagocytosis (Figure 16). As before, Mφ stimulated with LPS in a medium 
deprived of L-aspartate presented a significant increase of the superoxide anion levels (p =0.0271; 
Figure 16A) although the production of hydrogen peroxide was similar in both media (p =0.2115; 
Figure 16B). On the other hand, we did not detect any difference regarding the production of nitric 
oxide and phagocytosis after LPS-stimulation of these Mφ (Figure 16C-D).  
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Figure 16. Effector function evaluation of human Mφ differentiated in conditioned media after 
stimulation with LPS. Effector functions were evaluated by flow cytometry analysis in 24 hours LPS-stimulated Mφ 
after in vitro differentiation with GM-CSF or M-CSF in RPMIc (RPMI) or RPMI lacking L-aspartate (RPMI w/o ASP). The 
production of ROS was evaluated measuring the production of superoxide anion (O2-) (A) and hydrogen peroxide (H2O2) (B). The production of nitric oxide (C) and the percentage of phagocytosis (D) were also assessed. The data was obtained 
with cells derived from 6 different donors. p values were determined and differences were considered significant for * p ≤ 
0.05. 
 
 
Regarding mitochondrial analysis, we did not observed any significant differences in 
mitochondrial mass and potential indicating that Mφ differentiated in absence of L-aspartate do not 
present changes in mitochondrial biogenesis, even after LPS-stimulation (Figure 17A-B). 
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Figure 17. Mitochondrial evaluation of human Mφ differentiated in conditioned media after stimulation 
with LPS. Mitochondrial potential (A) and mass (B) were evaluated by flow cytometry analysis in 24 hours LPS-
stimulated Mφ after in vitro differentiation with GM-CSF or M-CSF in RPMIc (RPMI) or RPMI lacking L-aspartate (RPMI 
w/o ASP) media. The data was obtained with cells derived from 4 and 6 different donors. p values were determined and 
no significant statistical differences were obtained. 
 
 
Although these Mφ differentiated in conditioned media present distinct metabolic profiles, 
with the reduced numbers of independent samples tested so far we only detected minor fluctuations 
on their effector functions. However, the interaction between these different subsets of Mφ in a 
biological context may present a different functional phenotype. 
 
 
 
 
 
A B 
    
57  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
58  
 
 
 
 
 
 
 
 
 
 
 
 
  
59  
 
 
 
 
 
 
 
 
 
DISCUSSION AND FUTURE PERSPECTIVES 
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1. Metabolic and phenotypical characterization of human macrophages 
derived from CD14+ blood monocytes 
 
CD14+ blood monocytes consist in a heterogeneous population of circulating leukocytes that 
may ultimately originate Mφ or DCs upon recruitment to tissues. While some studies have started to 
elucidate the impact of different phenotypical profiles of these cells in physiologic and pathological 
conditions, the understanding of the role of metabolism and its impact on the acquisition of a certain 
phenotype is still scarce. Metabolic alterations are associated with the polarization profiles adopted 
by Mφ, as it has been shown recently with the expansion of the field of immunometabolism77. Mφ 
polarization is characterized by a continuum of functional phenotypes, canonically categorized by the 
in vitro M1 pro-inflammatory and M2 anti-inflammatory Mφ. These extremes of polarization are also 
associated with specific and divergent metabolic requirements. In order to understand how the 
metabolic alterations may impact the acquisition of a functional phenotype, we started by 
characterizing amino acid and carbohydrate metabolism during in vitro monocyte differentiation into 
Mφ and DCs. Our main objective was to associate specific metabolic requirements with the 
phenotype acquired by the CD14+ monocytes upon differentiation with different growth factors. 
Therefore, GM-CSF and M-CSF were used to differentiate blood monocytes into M1 and M2 Mφ, 
respectively59, while IL-4 + GM-CSF cocktail was used to differentiate monocytes into DCs114. The 
combination of IL4 and GM-CSF triggers the differentiation of DC through the inhibition of Mφ 
differentiation, since these differentiation pathways appear to be mutually exclusive. 
After comparison of the catabolic and anabolic profiles of each amino acid during monocyte 
differentiation, we evaluated the specific modifications occurring with Mφ comparing between them 
and with DCs. We observed that L-glutamine and L-aspartate are consumed during Mφ 
differentiation in the presence of GM-CSF or M-CSF, although L-glutamate levels do not suffer major 
alterations. On the other hand, monocyte-derived DCs show a higher consumption of L-glutamine and 
production of L-glutamate during differentiation, possibly derived from L-glutamine deamination. 
During the maturation process, DCs use glutamine to fuel the TCA cycle through glutaminolysis 
process, in which intramitochondrial L-glutamine is converted to α-ketoglutarate. This metabolic 
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process is induced by mTORC1 after GM-CSF signaling through PI3K/AKT, being this pathway 
essential in regulation of MYC complex expression, which is an essential step for the maturation of 
DCs115. The increase in mitochondrial mass and mitochondrial DNA is associated with a higher 
oxygen consumption and increased mitochondrial function that may explain the requirement of 
higher levels of L-glutamine to fulfill the TCA cycle. GM-CSF signaling and consequent regulation of 
these metabolic processes also explain the higher consumption levels of L-glutamine found in GM-
CSF differentiated Mφ when compared to Mφ differentiated with M-CSF. However, the observed 
consumption of L-glutamine after differentiation with GM-CSF is still lower when compared to 
monocytes differentiated with IL-4 + GM-CSF. Thus, it appears that the combination of these growth 
factors is important for the modulation of DCs and consequent metabolic requirements. 
Nevertheless, M-CSF has also been described to be responsible for slightly increased levels of 
glucose and L-glutamine catabolism in Mφ, through a Myc-dependent induction of cell cycle entry, 
that has been associated to a M2-profile of human Mφ or tumour associated Mφ (TAM) and this 
may explain the amino acid consumption levels by these Mφin our results116. Since a pro-
inflammatory stimulus, as LPS, is able to induce a complete opposite engagement of HIF-1α-
dependent glycolysis in Mφ, we hypothesize that GM-CSF, being associated to M1-Mφ profile, may 
induce a similar LPS-driven modulation of the metabolic activities of Mφ through a higher increase in 
glycolysis117. Therefore, the assessment of carbohydrate metabolism of these Mφ is important to 
understand their metabolic reprogramming after differentiation with M-CSF or GM-CSF.  
 Our results suggest that both L-glutamine and L-aspartate may play a role during Mφ 
differentiation from monocytes. Interestingly and in opposition to L-glutamine, L-aspartate is 
specifically consumed by Mφ but not by DCs. Therefore, our data led us to hypothesize that L-
aspartate might play an important role during Mφ differentiation. On contrary, we only observed 
glutamate production during DC differentiation. L-aspartate and L-glutamate are important amino 
acids for fuelling anaplerotic reactions in the TCA cycle and for metabolic processes such as the 
malate-aspartate shuttle, which is involved in the mitochondrial control of cellular bioenergetics 
status. Nonetheless, our results suggest that human Mφ and DCs present different amino acid 
requirements during their differentiation process from monocyte, putting forward a tempting and 
valuable field to explore. A positive correlation between the consumption of L-aspartate and L-
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glutamate was found when cells are differentiated in the presence of GM-CSF or M-CSF, which may 
be explained by the expression of glutamate aspartate transporter at plasma membrane of human 
Mφ118. This transporter is encoded by SLC1A3 gene and co-transport glutamate and aspartate to the 
cytoplasm by a symport mechanism. This transporter is also localized in the inner mitochondrial 
membrane as constituent of the malate-aspartate shuttle and it is crucial for the exchange of these 
amino acids with protons, which are essential for the production of ATP in the mitochondrial electron 
transport chain119. Our data suggest that in Mφ this symport mechanism is performed at a higher 
extension than in DCs, which is in accordance with the lack of correlations between L-aspartate and 
L-glutamate consumption or production profiles. However, regarding L-glutamine profiles, Mφ and 
DCs display opposite behaviors. A consumption of L-aspartate and L-glutamate is negatively 
correlated with L-glutamine consumption by M-CSF-differentiated Mφ. One possible explanation for 
these correlations is the deamination process of L-glutamine that upon arrival to the cell is converted 
to L-glutamate with production of ammonia (NH4+). The consequent production of L-glutamate is 
important for a variety of cellular functions, including the production of glutathione (GSH), which is 
essential for the maintenance of the antioxidant status of the cell. Accordingly, a higher consumption 
of L-glutamate and L-aspartate may limit the consumption of L-glutamine. In case of GM-CSF-
differentiated Mφ, there are no correlations with L-glutamine, probably because this amino acid may 
be used for other functions of cells as regulation of mitochondrial metabolic pathways. In contrast to 
Mφ, we observe no correlations between these amino acids in DCs, which indicate a distinct amino 
acidic metabolic profile for these cells. Future studies will address the metabolic fate of these amino 
acids in M-CSF or GM-CSF-differentiated Mφ. Overall we hypothesize that a metabolic link between 
the consumption and production of these non-essential amino acids is present during human Mφ 
differentiation, being the consumption and production profiles of DCs distinct during monocyte 
differentiation. 
The carbohydrate metabolism is also a gold example of how different metabolic 
requirements are associated with distinct polarizations phenotypes of Mφ. Thus, in order to 
understand the role of carbohydrates and how they are metabolized during human monocyte 
differentiation into Mφ and DCs, we decided to perform a characterization of carbohydrate utilization 
during differentiation of human CD14+ monocytes. Our results showed similar levels of glucose 
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consumption and lactate production during differentiation of Mφ. Nonetheless, when differentiated 
with GM-CSF, Mφ present a higher consumption of glucose and a higher production of lactate, when 
compared to DCs subset. However, comparing the different subsets of differentiated cells, the lactate 
production/glucose consumption ratios are similar. Higher glucose consumption and production of 
lactate levels are associated to higher glycolytic and fermentative rates that lead to a higher 
extracellular acidification rate (ECAR) of the medium by GM-CSF differentiated-Mφ120. The enhanced 
glycolysis and glutamine consumption observed in our results may indicate that during Mφ 
differentiation and specially with GM-CSF a metabolic stabilization of HIF-1α may occur as shown 
previously121. Succinate derived from glutamine-fueled aneplerotic reactions was shown to play a role 
in the enhancement of glycolytic process and in the production of interleukin-1β during 
inflammation81. It was previously described that M-CSF differentiated Mφ exhibit a significant higher 
oxygen consumption rate/ECAR ratio120. The increase in this ratio implies a higher mitochondrial 
activity, in detriment to fermentation. Although our results showed a similar ratio of lactate/glucose 
between differentiated Mφ and DCs, M-CSF differentiated-Mφ may present a lower glycolytic rate, 
especially if the mitochondrial OXPHOS process happens to be the main source of ATP production, 
as it happens to DCs. Our data also demonstrate that IL-4 + GM-CSF differentiated-DCs presented a 
lower glycolytic rate with consequent lower glucose consumption and lactate production. It was 
previously shown that after stimulation with TLRs agonists, DCs also present an increased 
consumption of glucose and production of lactate, which probably leads to an equally rapid 
production of ATP, essential for the activation state of these cells122. Nevertheless, before activation, 
the differentiation process of DCs may require mitochondrial OXPHOS to obtain energy. In line with 
our data, it has been described that after differentiation, DCs present increased content in 
mitochondrial DNA, as well as more efficient antioxidant systems and a higher expression of genes 
associated to mitochondrial biogenesis, such as PGC-1α123. Therefore, distinct bioenergetic profiles 
during monocyte differentiation may be important depending on the activation status of these cells.  
Mφ phenotypic markers have also been associated with different Mφ subsets upon 
stimulation and consequent polarization. In order to characterize DCs or Mφ after differentiation, we 
assessed by flow cytometry some phenotypical markers associated to human monocytes and Mφ: 
CD206, the mannose receptor C type 1 (MRC1), CD163, a scavenger receptor with high affinity for 
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the hemoglobin-haptoglobin complex, CD197, a C-C chemokine receptor type 7 (CCR7), and HLA-
DR, human leukocyte antigen - antigen D related. These markers are generally used to characterize 
populations of the monocyte/Mφ lineage and they are known to be associated with specific functions 
of these cells. CD206 and CD163 markers have been associated with anti-inflammatory profiles, 
while CD197 and HLA-DR have been linked to a more inflammatory profile of Mφ or to an activation 
state of DCs. Our characterization showed an increase of CD206 expression by GM-CSF 
differentiated Mφ and an increase in CD163 in M-CSF differentiated Mφ. DCs does not display 
CD163 expression that may be explained by the fact that GM-CSF and IL-4 factors strongly reduce 
CD163 expression during monocyte differentiation124. In contrast, CD206 is strongly induced by these 
two factors, which may justify the increase of CD206 expression in GM-CSF differentiated Mφ and 
DCs comparative to M-CSF-differentiated Mφ. A higher expression of CD206 marker and the higher 
percentage of CD206+CD163+ Mφ upon differentiation in the presence of M-CSF resemble an 
alternative activation of monocytes, which supports the reprograming of monocyte function to be 
more prone to act in an inflammatory context.. Indeed, the CD206 expression has been shown to be 
increased in CD14+ monocytes of patients with sepsis and was also correlated with the production of 
IL-17 pro-inflammatory cytokine characteristic of these patients125. Nevertheless, in this condition a 
modulation of monocyte function occurs with a consequent reduction of pro-inflammatory cytokines 
upon stimulation with LPS, which is present in alternatively activated Mφ. The analysis of CD197 
and HLA-DR showed no alterations between the distinct growth factors-induced profiles, being these 
markers associated to DCs or with LPS-stimulated Mφ. However, it has been described that tissue 
Mφ, such as alveolar Mφ differentiated in the presence of M-CSF, increase the expression of CD197, 
which could have a role in promoting the adaptive immune response through induction of migration 
to lymph nodes by a CCR7-dependent mechanism, what could be important during the early stages 
of an infection126. On the other hand, HLA-DR is a molecule involved in promoting adaptive immune 
responses and it is largely associated with DCs and antigen presentation127. Although our results show 
no statistical significance, there is a tendency for an increase of HLA-DR expression in DCs. The 
basal levels of this marker expression in DCs is associated to its maturation, since complete mature 
and functional DCs present higher expression of HLA-DR and are ready to complete their function in 
inducing adaptive immune responses. This phenotypical evaluation is essential for the 
characterization of human derived Mφ and DCs, crucial to understand how different growth factors 
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may induce changes in human monocytes, especially regarding the acquisition of different metabolic 
and phenotypical profiles. Moreover, the understanding of these functional and metabolic changes in 
tissues is essential for modulation of these differentiation profiles of cells during physiologic and 
pathologic conditions.  
 
2. Metabolic and phenotypical characterization of human macrophages 
derived from CD14+ blood monocytes in conditioned media 
 
The metabolic and phenotypical analysis of monocyte-derived Mφ and DCs led us to 
hypothesize about the exact contribution of amino acids for the phenotype and metabolic profile 
acquired by these cells. Our previous results showed a positive correlation of L-aspartate catabolism 
with other amino acids metabolism during Mφ differentiation. Also, the increase on L-aspartate 
consumption was specific to Mφ, irrespective of the growth factor, while it was not observed during 
DCs differentiation. Therefore, we decided to explore the metabolic and phenotypic profiles acquired 
by Mφ during monocyte differentiation in the absence of L-aspartate. This approach allowed us to 
explore how this amino acid may influence or not the phenotype and metabolic requirements of 
monocytes during in vitro differentiation. Accordingly, we started by characterizing amino acid and 
carbohydrate metabolism during in vitro monocyte differentiation in complete medium or medium 
lacking L-aspartate and compare the phenotype acquired by the CD14+ monocytes upon 
differentiation in these different media. 
Our results showed an increase in L-glutamate and L-glutamine consumption levels during 
differentiation in absence of L-aspartate, which may suggest a compensatory mechanism to obtain 
the required amino acid source for survival and differentiation. However, relevant differences were 
observed among Mφ differentiation with both factors. M-CSF differentiated Mφ present increased 
levels of L-glutamate and L-glutamine, while GM-CSF only present an increase in the consumption of 
L-glutamate. L-aspartate is a non-essential amino acid involved in several biosynthetic processes 
such as biosynthesis of proteins and synthesis of other amino acids such as methionine, threonine, 
isoleucine and lysine. Besides, this amino acid may also be involved in other homeostatic processes 
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of cells such as redox equilibrium. Our data lead us to speculate that different subsets of Mφ may 
use amino acids in a different way, ultimately resulting in the activation of different metabolic 
pathways. It is known that L-glutamate may originate L-aspartate by conversion of oxaloacetate into 
α–ketoglutarate, in the presence of aspartate aminotransferase (ASAT), which may enter in TCA 
cycle leading to the production of energy or other amino acids. In addition, L-glutamine may also 
originate L-glutamate by deamination reaction, important for the aneplerotic reactions. So, the 
increase in consumption of these two amino acids may be important to fulfill the TCA cycle leading to 
the production of energy by Mφ in order to maintain the basic functions of the cells. We also 
hypothesize that a deregulation of L-aspartate levels may lead to a dysruption of the malate-aspartate 
shuttle and a consequent break in ATP production in mitochondria. The L-aspartate supply may be 
replenished by L-glutamate and oxaloacetate. However, oxaloacetate pools have to be capable of 
transaminate and produce L-aspartate to maintain the conversion of malate with production of NAD+, 
essential for the malate-aspartate shuttle transport of electrons process and for the equilibrium of 
redox state of cell. This NAD+ produced is essential to the replenishment of the cytosolic pool of NAD+ 
essential for diverse metabolic pathways such as glycolysis. On the other hand, in the absence of L-
aspartate the consumption levels of L-glutamine are particularly higher comparing to the 
consumption levels of L-aspartate in RPMIc. This L-glutamine is being used as a compensatory 
mechanism for L-aspartate in the oxidative pathways to produce energy, but probably is also being 
used for reductive pathways such as FAS, essential for membrane cell remodeling and proliferation 
processes. 
Accordingly to our results, in the absence of L-aspartate Mφ differentiate using diverse 
amino acids as substrate to maintain cell survival. However, we do not know if this compensatory 
mechanism is effective for the nutrient supplying of the acquiring of a functional phenotype by Mφ. 
Glucose is used as a carbon substrate in the production of ATP, NADPH and precursors for the 
synthesis of macromolecules such as nucleic acids. Then, our next goal was to realize how 
monocytes use carbohydrates as a compensatory mechanism upon Mφ differentiation in medium 
without L-aspartate. The results showed that the abolishment of L-aspartate during monocyte 
differentiation do not alter glucose consumption and lactate production profiles of cells during 
differentiation. These results may explain the higher consumption of L-glutamine and L-glutamate 
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during differentiation in the absence of L-aspartate, once it is expected that these amino acids are 
used to originate TCA cycle intermediaries and produce energy. The glutamate originated from 
glutaminase reaction originates α–ketoglutarate in mitochondria that is oxidized to malate in TCA 
cycle. Malate can be exported to cytosol for conversion to pyruvate, which is used to the production 
of lactate through lactate dehydrogenase A, previously induced by MYC oncogene128. Another study 
also show that B cells may have a glucose-independent glutamine metabolism, being important for 
acquisition of different functions129. Although it seems that L-aspartate has a short effect on 
metabolism of M-CSF differentiated Mφ, we do not know how this amino acid is really involved in the 
metabolic changes and in the consequent phenotyping acquisition process by Mφ. Nevertheless, the 
metabolic characterization of these different subsets of differentiated Mφ allow us to realize that 
during the differentiation process the monocytes have different metabolic requirements depending on 
the differentiation factor and the nutrients that they receive.  
In order to assess the role of L-aspartate in the phenotypical characterization of monocytes 
differentiated with GM-CSF or M-CSF, we compared the expression of the markers previously 
analyzed in Mφ after differentiation in complete RPMI medium or in RPMI medium lacking L-
aspartate. Our results showed no differences between expression levels of different markers upon 
monocyte differentiation, leading us to suggest that no major phenotypical alterations occur in the 
absence of L-aspartate during monocyte differentiation into Mφ.  L-aspartate, a non-essential amino 
acid that can be synthesized by humans, showed to have a key role in modulation of amino acid 
metabolism, perceptible by higher increases in other amino acids consumptions profiles. However, 
the absence of this amino acid did not bring any alterations to carbohydrate metabolism or to 
phenotypical characterization of Mφ. Likewise, less is known about the reprogramming of the 
functional phenotype of these Mφ and its link to a physiologic or pathophysiologic context. 
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3. Functional characterization of human monocyte-derived 
macrophages differentiated in conditioned media 
 
The metabolic and phenotypical characterization of CD14+ monocyte differentiated Mφ in 
complete media and media lacking L-aspartate suggested a reprograming amino acid metabolism of 
monocytes. Thus, we decided to address how this metabolic reprogramming may influence a 
functional phenotype of human monocyte-derived Mφ, once the functional characterization of these 
cells is essential for the understanding of their role upon recruitment to the tissues. To evaluate the 
effector functions of Mφ differentiated in media with or without L-aspartate, we started to measure 
the levels of cytokines produced by Mφ after in vitro differentiation. We observed a decrease in the 
production of TNF-α in media lacking L-aspartate that may suggest these Mφ as reducing the 
production of inflammatory cytokines after differentiation without L-aspartate. These differences only 
were observed for GM-CSF-differentiated Mφ, having the Mφ differentiated with M-CSF a trend to 
produce lower levels of TNF-α also. Although these results are no statistical significant, GM-CSF 
differentiated Mφ also show a tendency to produce higher levels of IL-10 in the absence of L-
aspartate during monocyte differentiation. This decreased production of pro-inflammatory cytokines 
like TNF-α and increased production of anti-inflammatory cytokines production such as IL-10 may 
suggest an anti-inflammatory functional profile for these Mφ when differentiated in medium lacking 
L-aspartate. Although further studies as needed to increase the number of samples to ascertain this 
phenotype, this anti-inflammatory role of Mφ may be important in a biologic context, for instance in 
infection or tumoral settings. How these cells respond to a myriad of signals or even pathogens in 
different environments is paramount to determine the success of their effector functions, since it has 
been shown that anti-inflammatory Mφ are less efficient in pathogen clearance during infections. On 
the other hand, the role of these Mφ in a tumoral context may determine the progression and the 
severity of the tumor, once M2-Mφ may be associated to TAM51. We decided to evaluate other 
effector functions of Mφ and for that we assessed the mitochondrial status of these cells after 
differentiation in complete RPMI and in RPMI lacking L-aspartate. We analyzed by flow cytometry 
specific functions of Mφ such as phagocytosis, NO and ROS production in order to understand how 
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the effector functions of these Mφ may be altered or not after differentiation. We detected a tendency 
for a higher production of superoxide anion (O2-) and peroxide hydrogen (H2O2) molecules in the 
absence of L-aspartate. Although these differences are not statistical significant, the increase of ROS 
levels may be associated to a deregulation of mitochondrial function and, in a less extension, to a 
lower production of GSH which have an important antioxidant activity for the cell. We hypothesize 
that in absence of L-aspartate, L-glutamate probably is used in order to compensate the absence of 
L-aspartate, leading to a decrease in the production of GSH and consecutively to an increase in ROS. 
We also assessed the mitochondrial potential and mitochondrial mass to assess mitochondrial 
biogenesis and functionality of these organelles after differentiation of Mφ without L-aspartate. The 
results showed no alterations in mitochondrial status, being similar levels of mitochondrial mass 
indicative of no differences in mitochondrial biogenesis. However, it appears that mitochondrial 
potential is lower in absence of L-aspartate during differentiation of these cells. Although this 
difference in mitochondrial potential is not statistically significant probably due to the reduced 
number of donors, this result may indicate that the mitochondria are not functionally active and this 
may shift the metabolism in other direction for the successful production of energy. Indeed, the 
deregulation of mitochondria may also explain the higher levels of ROS production observed. ROS 
levels may also have a cytosolic origin and not exclusively mitochondrial. Deregulated levels of GSH 
and other antioxidant enzymes such as superoxide dismutase and catalase (for degradation of O2- 
and H2O2, respectively) may lead to an inefficient response in dealing to ROS reduction or an 
upregulation of systems producers of cytosolic ROS such as NADPH oxidase system may also be 
involved in increased levels of ROS. Therefore, it is important to address how these ROS are being 
produced and their role in the effector functions of these macrophages. In opposition, our results 
showed a trend to a decreased production of NO by these Mφ when differentiated in the absence of 
L-aspartate. As a note, the phagocytic capacity do not appear to be affected by the absence of L-
aspartate.  
Alltogether, these results suggest that Mφ differentiated in absence of L-aspartate present 
some altered effector functions that may lead to a lower performance in an inflammatory context, 
such as infections or tumors. Indeed, the decreased NO production for these cells and the lower 
levels of pro-inflammatory cytokines production in contrast to higher levels of anti-inflammatory 
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cytokines production lead us to speculate that these Mφ present some anti-inflammatory 
characteristics that may be prejudicial in an infection or tumoral context, but may be important in an 
non-reversible inflammatory environment as happens in autoimmune diseases. 
Accordingly, in order to assess the effector functions of Mφ in a context of stimulation, we 
decided to stimulate differentiated Mφ during 24 hours with LPS to see if there are any differences in 
effector functions upon stimulation. The results showed no significant differences in the production 
levels of IL-6, TNFα and IL-10 cytokines between Mφ differentiated in complete medium or medium 
lacking L-aspartate. Although it appears to exist a tendency to a lower production of IL-6 and a higher 
production of IL-10 in M-CSF-differentiated Mφ in the absence of L-aspartate, this difference is not 
statistical significant probably due to the heterogeneity of these human cells. However, with an 
increase of the number of donors, possibly the differences between the differentiation of Mφ in 
conditioned media will become more reliable. In this way, we speculate that these Mφ show a profile 
of cytokines that is consistent to a modulation of Mφ functions proper of a metabolic and functional 
reprograming. So, we decided to assess ROS and NO production and phagocytosis after stimulation 
with LPS. Differences in the production of O2- were observed, which may indicate that a higher 
production of O2- may be associated to deregulation of mitochondria activity or to an increase of 
cytosolic ROS. On the other hand, no differences were obtained in H2O2,, which may indicate different 
expression of catalase in comparison to superoxide dismutase (SOD) antioxidant enzyme. After 
analysis of mitochondrial function, we observed no differences in mitochondrial potential and in 
mitochondrial mass. These results suggest that Mφ differentiated in absence of L-aspartate do not 
have changes in mitochondrial biogenesis and the observed ROS may be originated by deregulation 
of superoxide dismutase antioxidant enzyme or upregulation of systems producers of ROS such as 
NADPH oxidase system leading to an increase of cytosolic ROS. Moreover, we did not detect any 
difference regarding the production of NO, which may lead us to speculate that in the presence of 
LPS these Mφ lose their capacity to produce NO. As before, the percentage of phagocytosis in the 
LPS-stimulation do not exhibit alterations, which may indicate that upon differentiation and 
consequent stimulation with LPS Mφ are prepared to respond in the same way.   
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After addressing the bioenergetic state of macrophages differentiated in conditioned media 
we observed that Mφ differentiated in absence of L-aspartate present some altered effector 
functions. In the future, we intent to increase the number of samples for monocyte differentiation into 
Mφ in conditioned media, in order to validate our results. Therefore, it is also paramount to address 
how ROS are being produced and their role in the effector functions of Mφ and how dysfunctional 
mitochondria may influence the energetic state of cell and consecutively may influence the functional 
phenotype of these cells in a biological context. In a metabolic perspective, it will be crucial to study 
the lipid metabolism in order to understand how the L-aspartate is being used or what metabolic 
compensatory mechanisms are being used in the absence of this amino acid. However, since the 
interaction between these different subsets of Mφ and a pathogen in an infection context, or since 
Mφ may display a distinct performance in a tumoral or inflammatory context, our main goal is to 
address the role of these Mφ in distinct inflammatory, infectious and tumoral contexts, in order to 
evaluate the effectiveness of the functional profiles of these Mφ.  
 
 
 
 
 
 
 
 
 
 
 
 
73  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
74  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
75  
 
 
 
 
 
 
 
 
 
CONCLUSION  
  
  
76  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
77  
Nutrient availability is essential for any immunologic process, being crucial for cell 
differentiation processes such as monocyte differentiation. A characterization of metabolic 
requirements of human CD14+ monocytes derived from peripheral blood mononuclear cells during 
differentiation in Mφ populations was performed in order to understand the different phenotypes 
acquired by these cells. The phenotypical and metabolic differences may originate functional 
changes in Mφ and DCs that are essential or deleterious depending on the tissues for where they 
are recruited. Moreover, the understanding of these functional and metabolic changes in tissues is 
essential for modulation of these differentiation profiles of cells during physiologic and pathologic 
conditions. During the characterization of amino acid and carbohydrate metabolism, we assessed 
and correlated different non-essential amino acids catabolic and anabolic profiles upon differentiation 
with different growth factors, comparing it with the different phenotypic profiles acquired by these 
cells. We revealed that amino acid catabolism of L-aspartate is important in monocyte-to-Mφ 
differentiation, but not for monocyte differentiation into DCs. Using a conditioned media, the absence 
of L-aspartate during monocyte differentiation cells led to compensatory mechanisms as 
demonstrated by the use of different amino acids, mainly L-glutamine and L-glutamate, as substrate 
to maintain cell survival for an effective supplying of nutrients in the acquiring of a functional 
phenotype by Mφ. Although it appears to induce a reprograming of monocytes into a different 
phenotype of Mφ, the assessment of Mφ effector functions was essential to understand the acquired 
phenotypic profiles of these cells during differentiation in a fully supplied environment or in an 
environment lacking a specific nutrient as L-aspartate. In the future, we want to assess the lipid 
metabolism in order to see how these different phenotypes of Mφ modulate lipid metabolism after 
monocyte differentiation in the absence of L-aspartate. Furthermore, we also want to address how 
these Mφ with distinct phenotypes may deal and present an effective response in distinct 
inflammatory, infectious and tumoral contexts in order to understand their functional phenotypes in a 
biological context. 
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Figure 18. Graphical conclusion of the main results of this work. Briefly, a metabolic characterization of human 
Mφ and DCs derived from CD14+ monocytes revealed distinct amino acid requirements upon differentiation with GM-
CSF, M-CSF or IL-4 + GM-CSF. We revealed that amino acid catabolism of L-aspartate is important in monocyte-to-Mφ 
differentiation, but not for monocyte differentiation into DCs. Using a conditioned media, the absence of L-aspartate during monocyte differentiation into Mφ led to alterations in consumption levels of amino acids and differences in 
effector functions of Mφ differentiated with GM-CSF or M-CSF: a decrease in TNF-α and NO levels and an increase in O2- 
and H2O2 production. After stimulation with LPS the alterations of effector functions only were maintained for GM-CSF-differentiated Mφ revealed by a decrease in TNF-α and IL-6 levels and an increase in IL-10 and in O2- production levels. 
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Supplementary figure 1. Gating strategy of Flow cytometry analysis. Gating strategy for the assessment of 
phagocytosis (A), for calculation of percentage of double positive cells (B) and for estimation of geometric mean 
fluorescence intensity of each phenotypic marker or probe used (C). 
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Supplementary figure 2. Amino acids consumption and production profiles upon human monocyte 
differentiation. The consumption (positive values) or production (negative values) of amino acids was quantified by 
HPLC (µM) in supernatants after 7 days of in vitro differentiation with GM-CSF, M-CSF or IL-4 + GM-CSF growth factors 
(A-I). Data was obtained from 23 different donors. p values were determined and no significant statistical differences were 
obtained. 
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Supplementary figure 3. Correlations between amino acids consumption and production profiles in 
human-derived DCs. Linear regression between the consumption and production profiles of each amino acid in the 
culture supernatant (µM) after 7 days of in vitro differentiation with IL-4 + GM-CSF (A-C). Data obtained with cells derived 
from 23 different donors. r2 and p values were determined and no significant statistical differences were obtained. 
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Supplementary figure 4. Correlations between amino acids consumption and production profiles in 
human monocyte-derived Mφ. Linear regression between the consumption and production profiles of each amino 
acid in the culture supernatant (µM) after in vitro differentiation with M-CSF (A, C ,E) or GM-CSF (B, D, F). Data obtained 
from 23 different donors. r2 and p values were determined. Differences were considered significant for p ≤ 0.05. 
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Supplementary figure 5. Characterization of other amino acids metabolism by human monocytes-derived 
Mφ in conditioned media in the presence of M-CSF. Amino acid concentration variation (µM) in culture 
supernatants after 7 days of in vitro differentiation with M-CSF in conditioned media (A-I). Data show mean values of Mφ 
differentiated in RPMIc (RPMI) and mean values of Mφ differentiated in RPMI without L-aspartate (RPMI w/o ASP). 
Scatter charts represent data obtained with cells derived from 6 and 8 different donors. p values were determined and 
differences were considered significant for * p ≤ 0.05. 
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Supplementary figure 6. Characterization of other amino acids metabolism by human monocytes-derived 
Mφ in conditioned media in the presence of GM-CSF. Amino acid concentration variation (µM) in culture 
supernatants after 7 days of in vitro differentiation with GM-CSF in conditioned media (A-I). Data show mean values of Mφ differentiated in RPMIc (RPMI) and mean values of Mφ differentiated in RPMI without L-aspartate (RPMI w/o ASP). 
Scatter charts represent data obtained with cells derived from 6 and 8 different donors. p values were determined and no 
significant statistical differences were obtained. 
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